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Diseases of the Retinal Pigment Epithelium-Photoreceptor Complex in Nonrodent
Animal Models
Abstract
Book Overview:
The retinal pigment epithelium is a critical tissue within the eye. It lies directly behind the retina, where it
provides metabolic support to the photoreceptors and controls their local environment. As a result, the
RPE is vital to retinal function, but also a site of aging and disease that cause dysfunction and visual loss.
This book brings together comprehensive reviews of basic and clinical science concerning the RPE. It is
organized to juxtapose chapters on RPE disease with chapters on the underlying pathophysiology. These
include up-to-date accounts of growth factors, laser effects, proliferative vitreoretinopathy, Bruch's
membrane pathology, as well as new diagnostic tools such as ocular coherence tomography, in vivo
imaging of lipofuscin and non-photic electrical responses. Other chapters cover pharmacology and
toxicology, mechanisms of retinal adhesion and detachment, RPE pigments and transport, congenital and
dystrophic diseases, animal models of RPE disease, and different aspects of age-related macular
degeneration. The history and evolutionary aspects of the RPE are also presented. The contributing
authors are experienced clinicians and eminent basic scientists who work on this critical part of the eye.
The book will be a valuable resource for anyone interested in the eye, and a necessity for specialists in the
fields of retinal physiology and retinal disease.
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14. Diseases of the retinal pigment
epithelium-photoreceptor complex
in nonrodent animal models
GUSTAVO D. AGUIRRE, JHARNA RAY

The retinal pigment epithelium (RPE) is strategically sit
uated between the photoreceptor cells and the choroid
to mediate a number of activities which are essential for
normal photoreceptor function and viability. Tradition
ally, these activities are considered to involve retinoid
transport, esterification and isomerization, the phago
cytosis and degradation of shed outer segments, and the
regulation of ion and metabolite transport. Additional
ly, evidence for the critical role played by the RPE in sus
taining the visual cells has been supported by studies
carried out in the Royal College of Surgeons (RCS)
strain of retinal-dystrophic rats. In these animals, post
natal retinal development is initially normal, but degen
eration begins soon after photoreceptor cells have dif
ferentiated normally. Disease occurs because the mutant
RPE is unable to internalize and degrade the outer seg
ment membranes that are discarded on a daily basis
from the distal tips of the photoreceptors (Herron et al.,
1969). This material appears as whorls of membranes
whose accumulation in the interphotoreceptor space
presages the degeneration and death of the visual cells.
Elegant studies by Mullen and LaVail (1976) have es
tablished that the target tissue for mutation is the RPE
and not the photoreceptors, and the phagocytic defect
can be examined in cell (Edwards and Szamier, 1977) or
organ (Tamai and O'Brien, 1979) culture, and the pho
toreceptor disease prevented by the transplantation of
genetically normal RPE cells (Li and Turner, 1988).
These and other studies carried out over the past
twenty years have identified the critical photoreceptor 
supportive roles played by the RPE. It has been estab
lished that primary dysfunction in the RPE can result in
visual cell pathology and cell loss. Similarly, abnormal
ities in the photoreceptor cells can elicit a pathologic re
sponse in the RPE, either very early in the disease
process or late, once the photoreceptor cells have de
generated and disappeared. In other cases, however, the
RPE plays a passive role, demonstrating minimal re
sponse to the very severe disease that is occurring in its
surround. An explanation for the varied repertoire of
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disease and responsiveness demonstrated by the RPE
lies in its complexity and varied functional roles. The
RPE can no longer be considered a simple epithelial
monolayer with uniform function and behavior. In
stead, it must be regarded as a highly complex cell
whose cytologic and functional properties are deter
mined or modified by positional and topographic fac
tors. This chapter examines the role of the RPE in dis
eases of the pigment epithelial-photoreceptor complex
in selected domestic animal species. In some cases, the
diseases occur sporadically in animals, but the RPE re
sponse is so unique that it provides insights into RPE bi
ology or pathology. In other cases, the diseases, which
were once identified as naturally occurring primarily in
the dog and cat, are now maintained in laboratory col
onies. As a result, the models have the same gene defect
and demonstrate a consistent disease phenotype that
lends itself readily to experimental study and analysis.
NORMAL ANATOMY
The histology of the RPE of domestic animals is influ
enced by its relationship to the tapetum lucidum, a
choroidal modification that is located between the large
choroidal vessels and the choriocapillaris. In dog and
cat, the tapetum consists of rows of multilayered, flat,
often irregularly shaped cells (tapetum celhilosum; Fig.
14-1). Ultrastructurally, the cytoplasm of the tapetal
cells contains groups of elongated membrane-bound
rods that are electron-dense, are oriented parallel to
each other, and are uniform in size and spacing. The
rods are separated from each other by amorphous
ground substance, and by very fine fibrils and filaments.
Within each cell, there are several groups of rods, each
group having its own characteristic and independent
orientation (Bernstein and Pease 1959). However, the
rods are all arranged in a plane parallel to the pigment
epithelial basement membrane (Fig. 14-2).
Differences in tapetal structure, organization, and
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FIGURE 14-1. Anatomic relationship of the tapetum lucidum (TI),
retinal pigment epithelium, and photoreceptor cells in the posterior
pole of the dog eye. The outer retina is nourished by arterioles from
the choroid (open star, left) which penetrate through the tapetum and
spread horizontally between the tapetum and retinal pigment epithe
lium to form the choriocapillaris, Magnification X650.
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composition have been noted in the past by several in
vestigators, and these differences appear to be species
specific (see Pirie, 1966 for review). Recent studies have
examined the tapetum lucidum in the dog and cat (Bus
sow, 1980; Burns et al., 1988; Wen et al., 1985) and
found that, although superficially similar in the two
species, there are many differences in structure, cell
number, and chemical composition (Table 14-1). Unlike
in the dog, the tapetal rodlets in the cat retain an elec
tron-dense core after fixation, and have a single ring
rather than concentric rings of zinc deposition, as visu
alized with a sulfide-silver histochemical method (Wen
et al., 1982; 1985). The peripheral rather than internal
distribution of zinc around the tapetal rodlets of the cat
may account for the tenfold-lower concentration of this
divalent cation in the tapetum in comparison to the dog.
In the latter species, the zinc is complexed to cysteine,
which occurs in higher concentration in the dog tape
tum than in any other tissue (Wen et al., 1982).
In contrast to carnivores, herbivores have a fibrous
tapetum (tapetum fibrosum), consisting of bundles of
undulating collagenous fibers arranged somewhat con
centrically and with an iridescent surface. Except for an
occasional fibrocyte, the fibrous tapetum is basically

FIGURE 14-2. The tapetum lucidum (TI) consists of a multilayer of flattened cells. Each cell contains
groups of membrane bound rods oriented parallel the basement membrane of the retinal pigment epithe
lium. Note the prominent choriocapillaris layer (star). In the tapetal zone, the pigment epithelium is not
pigmented; the cytoplasmic granules are lipofuscin. Magnification XS,800.
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TABLE 14-1. Comparison of the morphological and
histochemical parameters of the mature tapetum
lucidum of the dog and cat

Parameters

Dog

Number of tapecal cell layers
9-11
(central)
Thickness of central rn petum
26-33 µm
Thickness of retina from the
151-184 fLID
area of center tapetum
Presence of a microtubule-like
present
structure in each tapetal rod
Presence of electron-dense cores
absent
in tapetal rods after prolonged
glutaraldehyde fixation
Distribution partern of zinc
two concentric
in tapetal rod
rings
Zinc in tapetum (PPM)
26,000 1,100
Cysteine in tapetum
241 ::':: 18
(µ�Ilg tissue) (n 6-8)
Modified from Wen et al., 1982; 1985

Cat

16-20
61-67 µm
145-150 µm
absent
present
one outer
ring
1,497 152
0

acellular (Bellairs et al., 1975). In the cow, this layer can
be up to 50 µm thick, with the collagenous bundles ori
ented in a plane parallel to the RPE basement membrane
(Nakaizumi 1964). Pig, rabbit, rat, guinea pig, and most
higher primates lack a tapetum.
Blood supply to the RPE and outer retinal layer in the
tapetal regions is derived from the large choroidal ves
sels external to the tapetum. Smaller vessels penetrate
this layer and branch extensively under the tapetum,
forming an incomplete choriocapillaris layer. In the dog
and cat, the choriocapillaris forms a thin vascular zone
interposed between the tapetal cells and the basal sur
face of the RPE. Occasionally, however, deep invagina
tions of the choriocapillaris into the basal RPE are seen.
In the nontapetal regions, the choriocapillaris is adja
cent to the larger choroidal vessels. In both tapetal and
nontapetal regions, there are multiple fenestrations in
the thin endothelial wall of the choriocapillaris adjacent
to the RPE.
Unlike the human, the dog and cat lack a well-defined
Bruch's membrane. The RPE and choriocapillaris base
ment membranes are apposed, with infrequent collage
nous and elastic fibers present between the two. In the
intercapillary space of the tapetal and nontapetal re
gions, more collagenous and elastic fibers are present,
and a more classical Bruch's membrane is occasionally
recognized. Of all the domestic species, the pig has the
most prominent Bruch's membrane (Prince et al., 1960).
The topographic variation in tapetal distribution is
reflected in the differing cytologic characteristics of the
RPE. The most obvious of these is the presence of

melanin granules. Melanin is absent in areas overlying
the tapetum, although sparse pigmentation begins to ap
pear in junctional zones, either centrally or peripheral
ly. In these areas, the tapetal thickness gradually de
creases to one or two cells, and melanin granules are
present. As the ta petal cells disappear, the degree of pig
mentation increases. In general, RPE cells are smaller
and have less-dense pigmentation in the posterior pole,
and increase both in size and in extent of melanin pig
mentation peripherally. The topographic distribution of
pigmentation in relation to the tapetum is illustrated in
Figure 14-3. However, the elegant studies of the human
RPE, which examine the cell number and size, and the
degree of pigmentation and lipofuscin accumulation in
relation to age and topographic position have not been
done in nonprimate species (see Dorey et al., 1989; Gao
et al., 1992; Feeney-Burns and Ellersieck, 1985; Feeney
Burns et al., 1984). This limitation interferes with stud
ies examining disease processes in the RPE-photorecep
tor interface.

THE RPE IN DISEASES OF THE TAPETUM LUCIDUM
Hereditary Diseases
Hereditary abnormalities of the tapetum lucidum have
been described in beagle dogs (Bellhorn et al., 1975;
Burns et al., 1988) and Siamese cats (Wen et al., 1982;
Collier et al., 1985a). In dogs, the disease is autosomal
recessive, and affected animals lack the normal tapetal
reflex visible on ophthalmoscopy; instead, the fundus
has a uniform red appearance without the topographic
separation of ta petal and nontapetal zones (Burns et al.,
1988) (Plates 14-1, 14-2). Unlike the albino fundus,
where the lack of RPE and choroidal pigmentation per
mit visualization of the choroidal vasculature overlying
the white sclera (Plate 14-III), dogs with the hereditary
tapetal defect have a light, uniform choroidal pigmen
tation which precludes visualization of the choroidal
vessels. With the exception of the foveomacular region,
which is not present in nonprimate species, the fundus
appearance is quite similar to that of a lightly pigment
ed human.
In affected dogs, there are normal numbers of tapetal
cells at birth, but, with time, there is a progressive de
generation of this layer; in adult animals, the remaining
layer of dysmorphic tapetal cells is only 1-2 cells thick
(Fig. 14-4; Burns et al., 1988). Ultrastructural disease is
evident in cells as early as 46 days after birth by the loss
of the normal complement of ta petal rodlets, and the ac
cumulation of cytoplasmic membranous whorls (Fig.
14-5). At this age, the normal tapetal cells are in the
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Right eye
Normal cat

It month• of 1111•1

temporal

FIGURE 14-3. Schematic representation of the distribution of PE pig
mentation and the presence of the tapetum lucidum in the eye of a nor
mal cat. For comparison with the disease (MPS VI) see Figure 14-26.
The eye is drawn to scale based on observations of sequential 150 µ.m
fields extending from the disc to the ora serrata (curved line). Note
that the tapetum is present primarily in the superior, nasal, and tern-

poral meridians. The pigment epithelium is not pigmented in areas
where the tapetum is present. Key: arrows indicate the presence of
tapetum; RPE pigmentation varies from absent (empty) to moderate
(density present in the far periphery). (For details refer to Aguirre et
al., 1983, from which this figure was reprinted.)

process of postnatal differentiation. By 13 weeks of age,
the abnormal tapetal cells contain only membranous
whorls and membrane-limited inclusions. These abnor
malities are characteristic of the process of tapetal cell
degeneration. Associated with the cytologic abnormali
ties, the tapetal rodlets fail to show an identifiable zinc
signal by X-ray microanalysis, either in very young (21
days) or adult animals (17 months) (Burns et al., 1988).
In spite of the severe disease that is occurring in the
tapetal layer, the RPE remains normal, and retinal func
tion and structure are preserved.
Similar tapetal degenerative changes have been iden
tified in cats with Chediak-Higashi syndrome (CHS;
Collier et al., 1985a), and, in both diseases, there is a
striking absence of phagocytic cells during the active
process of tapetal cell degeneration. As in the atapetal
beagle, tapetal cells in CHS cats develop normally dur-

ing the early postnatal period. However, the intracellu
lar rods begin to degenerate by four weeks of age, and
are completely degenerated by two months of age, a
time by which postnatal retinal differentiation is com
pleted (Vogel, 1970). Thereafter, the disrupted tapetal
cells begin to degenerate, and this choroidal layer is lost
by one year of age.
The tapetal pathology identified in cats with CHS is
presumably unrelated to abnormalities in the RPE, since
these occur uniformly across the monolayer as well as
in other tissues (Collier et al., 1984). The disease is char
acterized by greatly enlarged cytoplasmic granules, in
cluding melanosomes and lysosomes. In the RPE of
young affected animals, very few melanosomes are
present, and most of the melanin granules are giant
sized. These giant granules are composed of several
melanosomes and premelanosomes in different stages of
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FIGURE 14-4. Tapetal region from beagles affected with a hereditary
degeneration of the tapetum lucidum at different stages of the disease.
(a) 7 days old. The tapetal cells (T) form a loose, irregular meshwork
between the RPE and choroid (C). Vessels (V) penetrate the tapetum
and form the choriocapillaris (CC). (b) 21 days. The tapetal layer (T)
is more regular, and the photoreceptors (P) are differentiating. (c) 46

days. The retina (R) and RPE are normal. The ta petal layer (T) is thin
ner, but the remaining cells, although lightly staining, retain normal
shape. (d) 17 months old. The tapetum (T) has almost disappeared,
but the RPE and retina (R) are normal. Bar = 100 µm. (Reprinted
from Burns et al., 1988.)

maturation, and contain lysosomal and melanosomal
components (Collier et al, 19856). The giant granules
appear to form by inappropriate fusion of cytoplasmic
structures, and the hypopigmentation of the RPE likely
results from fusion of premelanosomes and lysosomes,
with resultant destruction of the former. In the RPE
of older animals (>7 years), numerous variably sized
autofluorescent inclusions accumulate which, on ultra
structural examination, are identified as secondary lyso
somes. Additionally, extracellular giant residual bodies
form drusenoid accumulations benc;ath the basal lami
na of the RPE. These abnormalities are associated with
focal reactive and degenerative changes of the RPE,
characterized as focal cells loss, detachment, and mi
gration into the interphotoreceptor space (Collier et al.,
1986).
Although the involvement of the lysosomal system in
CHS is evident by the abnormal fusion of lysosomes, it
is clear that lysosomal function is normal, at least in re
gards to the degradation of proteoglycans associated

with the RPE extracellular matrices, or of glycoproteins
internalized during phagocytosis of photoreceptor out
er segments (see below). This has been confirmed by
studies which demonstrate that there is little effect on
endocytic and degradative functions, even though dis
ease affects the late endosomes and lysosomes and may
result in the abnormal secretion of some lysosomal en
zymes into the media by cultured cells (Burkhardt et al.,
1993; Zhao et al., 1994). Of interest have been the re
cent complementation studies using normal fibroblasts
and fibroblasts from CHS-affected humans, mink, and
mice. The normal human fibroblasts complemented the
CHS fibroblasts regardless of the species, resulting in
restoration of normal lysosomal size and distribution;
this finding suggests the homology between the diseases
occurring in the different species (Perou and Kaplan,
1993).
The tapetal defect described in the Siamese cats is not
a specific hereditary defect within the breed, but appears
to be part of the overall genetic makeup of the breed.
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FIGURE 14-5. Degenerating tapetal cell from a 46-day-old beagle with
hereditary tapetal degeneration. The tapetal rods have degenerated
and the cell is filled with inclusions. The membrane whorl appears to
have originated from the rough endoplasmic reticulum, and ribosomes
are present inside or at the outer border (arrows) of the whorl. Bar =
1 µm. (Reprinted in part from Burns et al., 1988.)

Other breed-specific characteristics reported are differ
ences in fur and ocular pigmentation, strabismus, and
abnormalities in the retinogeniculate and cortical pro
jections (see Wen et al., 1982 for review). Even though
the ophthalmoscopic appearance of the tapetum is nor
mal in Siamese cats, microscopic abnormalities have
been identified in some animals, and consist of weakly
staining tapetal cells on light microscopic examinations.
On ultrastructural examination, the abnormal cells are
filled with irregular and disoriented tapetal rods whose
membranes are enlarged or disrupted. The cores of the
tapetal rods appear empty, or are filled with an electron
dense material. These abnormalities are not present uni
formly in all tapetal cells, but vary in different layers.
Overall, however, disease of individual tapetal cells is
most severe in the retinal aspect of the tapetum. Associ
ated with the tapetal abnormality is a significant reduc
tion in the amount of zinc in the tapetal rods (Wen et al.,
1982). The causal association between the lower levels
of zinc and the tapetal cell degeneration is not clear at
this time. In spite of the damage to the tapetal cells, the
RPE remains normal (Aguirre, unpublished).

Acquired Defects: Nutritional and Toxic Damage
Tapetal defects in cats have been reported secondary to
a nutritional deficiency of taurine (Wen et al., 1979). In
affected cats there is a marked reduction in thickness as-

265

sociated with a decrease in cell number. Additionally,
there is a marked disorganization of the lattice arrange
ment of the tapetal rods. This abnormality is associated
with a taurine-associated progressive degeneration of
the cone and rod photoreceptors, with sparing of the
RPE (Aguirre and Rubin, 1979: Fig. 19.23).
The most common· causes of acquired tapetal defects
have been reported in ophthalmic toxicology studies,
particularly of dogs, where administration of various
compounds results in dramatic changes in the tapetum
which are visible on ophthalmoscopy, histopathology,
and ultrastructural examination (Figs. 14-6, 14-7). The
prototype compound to produce this effect is the anti
tubercular drug ethambutol. Administration of this
compound to dogs causes a decoloration of the tapetum
and a reversible disorientation of the tapetal rods with
no RPE or retinal damage (Kaiser, 1963; Vogel and
Kaiser, 1963). More-severe tapetal damage occurs in the
dog following administration of the potent zinc chela
tor diphenylthiocarbazone (dithizone). There is retinal
edema, pigmentary disruption, and end-stage retinal de
generation with intraretinal pigmentation at the higher
doses. It appears, however, that the tapetum may play a
protective role in ameliorating dithizone toxicity of the
retina. In the tapetal area, dithizone causes tapetal
necrosis while sparing the underlying RPE and retinal
layers. In contrast, areas devoid of tapetum show severe
RPE and retinal degeneration (Aguirre and Rubin,
1979). Similar neuroretinal damage has been reported
in animals without a tapetum (Budinger, 1961, Butturi
ni et al., 1953).
Tapetal lesions also have been reported with various
classes of compounds, not all of which are known zinc
chelators. For example, administration of zinc pyrid
inethione (Cloyd et al., 1978), selected beta-adrenergic
blocking agents (Schiavo et al., 1984), macrolide an
tibiotics (Massa et al., 1984), aromatase inhibitors
(Schiavo et al., 1988), and other compounds can cause
varying degrees of tapetal damage in the dog or cat
(Cloyd et al., 1978). Where damage is acute and severe,
such as with zinc pyridinethione, the necrotic changes in
the tapetum result in damage to the penetrating tapetal
arterioles. This causes focal lesions, presumably infarcts
in the RPE and retina, which are evident as focal areas
of subretinal edema and hemorrhage. When the lesions
are more severe, there is diffuse subretinal edema, reti
nal detachment, and blindness (Cloyd et al., 1978). In
this case the RPE appears to be damaged secondarily by
the severe changes occurring in the adjacent tapetal lay
er, and displays a breakdown of the outer blood-retina
barrier. In other cases, for instance following the ad
ministration of an aromatase inhibitor (Schiavo et al.,
1988), tapetal damage is selective and limited to this cell
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A

FIGURE 14-7. Ultrastructural appearance of tapetal degeneration in
duced by chronic administration of a tapetotoxic compound. There is
loss of tapetal cells. Remaining cells have disorientation of the rodlets
(•), and accumulation of vacuoles (V) and membrane whorls (open
a"ow). Magnification X10,000. Compare with Figure 14-5.

ular abnormalities in dogs lacking a tapetum (Cloyd et
al., 1978; Massa et al., 1984; Schiavo et al., 1984).
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B
FIGURE 14-6. Chronic administration of a tapetotoxic compound re
sults in tapetal degeneration in the dog. In some areas there is loss of
tapetal cells (A) and the RPE abuts the vascular choroid (v). In other
areas, the few remaining tapetal cells have vacuolated inclusions (ar
rows, BJ. Arrowhead indicates indentation of the normal RPE by the
choriocapillaris. Magnification X680.

layer; thus the RPE and retina remain normal. The dif
ferential expression of the compound-associated dam
age between the tapetal and nontapetal areas is intrigu
ing, and raises concerns about the interpretation of
tapetal lesions in animals used in toxicologic studies.
For that reason, several studies of potentially tapeto
toxic compounds also use atapetal dogs having the
hereditary absence of this structure (Burns et al., 1988).
It has been clearly demonstrated that, in contrast to the
findings in normal dogs, these compounds cause no oc-

Hereditary diseases affecting the rods and cones, either
primarily or secondary to an RPE defect, are recognized
in a number of different species including man. Regard
less of the underlying cause, the diseases appear to af
fect the photoreceptors early and progressively; in the
advanced stages, the entire visual cell layer is destroyed,
and there is damage also to the inner retinal layers and
the RPE. In man, this class of diseases is referred to, col
lectively, as retinitis pigmentosa (RP). Multiple loci for
RP have been recognized, but few genes have been iden
tified (see Dryja and Li, 1995 for review). Recent stud
ies of retinal degeneration in human patients and animal
models have identified mutations in six different genes
(rhodopsin, peripherin/rds, rom-1, a and 13 subunits of
rod cyclic GMP-phosphodiesterase [PDEA and PDEB],
and the cyclic GMP-gated channel) as causally associat
ed with RP (Humphries et al., 1992; Kajiwara et al.,
1991; 1994; Travis et al., 1989; Bowes et al., 1990;
Suber et al., 1993; McLaughlin et al., 1993; Dryja et al.,
1995; Huang et al., 1995). Some of these genes
rhodopsin, rom-1, PDEB--are expressed exclusively in
the rod photoreceptor cells, yet the clinical and patho
logic phenotype of RP and related diseases indicates that
there is progressive rod and cone degeneration with a
late and secondary involvement of the RPE. It appears
that all defects that cause widespread disease and de-
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generation of rods, regardless of the selective expression
of the gene product in rods, result in the concomitant
loss of cones, and progressive retinal degenerative dis
ease.
The manner in which cellular dysfunction, disease,
and degeneration are expressed in the visual cell layer is
dependent, to a large extent, on the gene affected and
the nature of the mutation. However, different muta
tions of the same gene can result in a varied clinical phe
notype, for example with opsin (Berson et al., 1991;
Dryja et al., 1993) and peripherin/rds (Weleber et al.,
1993) genes, and factors external to the visual cell may
also play a modulatory role to influence the temporal,
topographic, or cellular distribution of the disease. In
this brief overview, we discuss different aspects of pho
toreceptor disease from the perspective of the RPE.
Progressive Retinal Atrophy (PRA) in the Dog

The PRA class of diseases represents a heterogeneous
grouping of retinal disorders having similar disease phe
notype. Like RP in man, the term PRA represents an ag
gregate of different genetic defects having a broadly sim
ilar clinical phenotype. All show the same general
ophthalmoscopic abnormalities (Plate 14-IV) and visu
al deficits characterized initially by rod dysfunction fol
lowed by loss of day vision; in the late stages of the dis
ease, the animals are blind, have end-stage retinal
degenerative changes, and secondary cataracts. Exclud
ing the absence of intraretinal pigmentation, which ap
pears to be a property unique to the human retina with
advanced photoreceptor disease, the clinical phenotype
of PRA in dogs is similar to RP in man.
Within this general grouping, PRA is subdivided into
developmental and degenerative diseases (Table 14-2).
The developmental class represents a large grouping of
genetically distinct disorders which are expressed cyto
logically in the postnatal period, at the time that visual
cells are beginning to differentiate. These developmen
tal disorders represent a dysplasia of the rod and/or
cone photoreceptors, and each has its own unique dis
ease course and phenotype, as assessed by functional
and morphologic criteria (Aguirre, 1978; Adand and
Aguirre, 1987; Acland et al., 1989; Parshall et al.,
1991). Even though all dysplasias show rather severe
structural alterations of the photoreceptor cells, the rate
of progression to loss of cones, the hallmark criteria for
loss of functional vision, is varied; e.g., this occurs ear
ly in the erd, rcd1 and rcd2 retinas, but not until the
equivalent of middle age in pd and rd. In contrast, the
degenerative class of diseases represents defects in which
photoreceptor cells degenerate after having differentiat
ed normally; this class includes diseases at the progres-
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14-2. Gene loci for hereditary photoreceptor
diseases in dogs

TABLE

Disease name

Gene locus

Progressive Retinal Atrophy (PRA)
I. Abnormal Photoreceptor Development
Rod-cone dysplasia 1
rcdl
Rod-cone dysplasia 2
rcd2
Rod dysplasia
rd
Early retinal degeneration
erd
pd
Photoreceptor dysplasia
II. Photoreceptor Degeneration
prcd
Progressive rod-cone
degeneration
XLPRA
X-linked PRA
Other Primary Photoreceptor Diseases
Cone degeneration
cd
csnb
Congenital stationary
night blindness

Genes excluded/included

PDEB (codon 807-stop)
PDEB, transducin ix-1
RDS/peripherin, opsin,
PDEB, transducin ix-1

RDS/peripherin, opsin,
PDEB, transducin ix-1

Transducin r33

Dara from Aguirre and Acland, 1988; Acland et al., 1989; 1994;
1995; Aguirre and Rubin ] 974; Akhmedov et al., 1997; Ray et al.,
1996, 1997; Wrigstad, 1994.

sive rod-cone degeneration (prcd) and XLPRA gene loci
(Aguirre et al., 1982a; Aguirre and Acland, 1988;
Acland et al., 1994). Here, disease occurs more slowly,
and is modified by temporal and topographic factors
(see below). Different alleles have been identified at the
prcd locus (Aguirre and Acland, 1988), and these seg
regate independently to regulate the rate, but not the
phenotype, of photoreceptor degeneration (Acland and
Aguirre, unpublished), Examples are presented below.
Photoreceptor Dysplasias, Abnormal Retinal cGMP
Metabolism and Retinal Degeneration

Rod-cone dysplasia 1. Rod-cone dysplasial (rcd1) in
the Irish setter is a recessively inherited photoreceptor
defect characterized by arrested differentiation of visu
al cells resulting from an abnormality in retinal cyclic
GMP (cGMP) metabolism (Aguirre et al., 1978; 1982b).
Beginning at ten days of age, deficient cGMP-phospho
diesterase (cGMP-PDE) activity causes the retinal levels
of cGMP to rise sharply to concentrations up to tenfold
higher than normal; these biochemical abnormalities
are present before degenerative changes are observed in
the photoreceptor cells (Fig. 14-8). The morphologic
and biochemical phenotype of the disease is similar to
that present in the rd mouse (Farber and Lolley, 1974).
Homology between the dog and mouse diseases, as well
as to some forms of RP in man, has been established by
identification of mutations in the PDE-Beta (PDEB)
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PATTERN OF CYCLIC GMP DEVELOPMENT IN
CONTROL AND AFFECTED RETINAS
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FIGURE 14-8. Developmental pattern of changes in cGMP concentra
tion with age in retinas from dogs affected with rcdl (Irish setter, up
per panel) and rcd2 (collie, lower panel). Normal values (solid circles)
from controls are included in each figure. In both rcdl and rcd2, lev
els of cGMP increase early in the postnatal period to values 8-10 times
higher than normal. (Modified from Chader et al., 1985.)

subunit gene as being responsible for the diseases in the
three different species (McLaughlin et al., 1993; Bowes
et al., 1990; Farber et al., 1990; 1992; Suber et al.,
1993). Not surprisingly, human RP patients with ab
normalities in the PDEB gene show a varied mutation
spectrum (McLaughlin et al., 1995). In contrast, the
same two different abnormalities have been identified
concurrently in all rd strains examined (Pittler and
Baehr, 1991; Bowes et al., 1993), while all rcdl-affected
dogs have the same mutation in codon 807 (TRP807x),
which presumably results in the pr�mature termination
of the PDEB protein by 49 amino acid residues (Clement
et al., 1993; Ray et al., 1994 and 1995).
A question arises about the specificity of the abnor
mal retinal cyclic nucleotide metabolism, and whether it
is limited to the visual cells. In our original study, we
found that retinal cGMP levels were elevated in retina,
but not in the RPEJchoroid complex or in nonocular tis
sues (Aguirre et al., 1978). Subsequently, using the reti-

nal layer microdissection method of Lowry, Barbehenn
and colleagues (1988) found that the elevated retinal
cGMP levels are confined to the photoreceptor cells.
Since the outer segments .of the affected visual cells are
small, and degenerate early, the elevated cGMP levels
are not located in this structure but, rather, are present
in the outer nuclear and plexiform layers (Barbehenn et
al., 1988). Such abnormally high levels of cGMP in the
synaptic terminals are unexplained, but may indicate
aberrant sites of synthesis or trafficking of newly syn
thesized cyclic nucleotides in the dysplastic rod pho
toreceptors. Additionally, more recent studies indicate
that there are no abnormalities in cyclic nucleotide lev
els in cultured RPE cells of rcd1 -affected dogs, further
confirming the specificity of the defect to the visual cells
(Table 14-3; Stramm, Fletcher, Aguirre, and Chader, un
published).
In red 1-affected dogs, there is normal retinal structure
and opsin biosynthesis during the first two weeks of life.
However, at the time when photoreceptors begin to dif
ferentiate in the normal retina (13-16 days), develop
ment of rods in the rcd1 retina is arrested, and the dis
eased cells begin to degenerate; by 25 days after birth,
photoreceptor cell death begins, and this process con
tinues throughout the first year of life (Fig. 14-9)
(Aguirre et al., 19826; Schmidt and Aguirre, 1985). The
degeneration initially affects the rods, and, as these cells
degenerate, the proportion of cones in the visual cell lay
er increases. However, cone degeneration develops
eventually, and results in collapse of the interphotore
ceptor space, bringing into close apposition the apical
surfaces of the RPE and Muller cells. In spite of the se
vere disease that is occurring in the apposing visual cell
layer, the RPE remains normal and minimally reactive,
and, as is characteristic of hereditary retinal diseases in
nonprimate models, there is a lack of intraretinal pig
ment migration.
Photoreceptor-RP£ interactions occur through the
interphotoreceptor matrix (IPM). Until recently, this
matrix was ill defined, and its structural and functional
characteristics were not clear. The IPM is now known
to be a complex and highly ordered structure consisting
of soluble and insoluble constituents in which proteins,

14-3. Cyclic nucleotide levels {picomole/mg
protein) in primary cultures of RPE cells from ten
week-old normal, carrier, and red 1-affected dogs

TABLE

Nucleotide

cAMP
cGMP

Normal

Carrier

Affected

3.1 :t 1.6
1.8 :t 1.7

3.9 :t 2.9
1.8 :t 1.1

2.2 :t 0.2
1.2 :t 0

Unpublished data from Stramm, Fletcher, Aguirre, and Chader.
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FIGURE 14-9. Retinas from normal (A 1 -4) and rcdl-affected Irish set
ters (B 1_6) of different ages. Normal: A 1-4 = 10 days, 13 days, 26 days,
and adult. Affected: B 1_4 = 9 days, 16 days, 33 days and 57 days; B5,6
= 1 year. In the normal dog, the inner segments are distinct by 10 days,
and outer segments have elongated to near adult proportions by 26
days. The adult retina has a high photoreceptor density, and the rods
outnumber the cones (arrows in A4). The rcd1 retina shows normal
development at 9 days of age. At 16 and 33 days of age, the rod inner
segments have not elongated, and the outer segments are short and
disorganized. Loss of rods results in increased prominence of cones
(arrows in B3 4), and thinning of the outer nuclear layer. By 1 year of
age, photore�eptor loss is extensive. At all stages of the disease, the
RPE is normal. Magnification X400. (Reprinted from Farber et al.,
1992.)

glycoproteins, enzymes (acid hydrolases, etc.), glycosam
inoglycans (GAGs), proteoglycans, and other molecules
are localized (see Hageman and Johnson, 1991 for re
view). Within the insoluble matrix, individual rods and
cones are invested by photoreceptor type specific do
mains (Hageman and Johnson, 1991; Mieziewska et al.,
1991). A matrix disorder that affects either its synthesis
or maintenance could adversely affect these two cell lay
ers; alternatively, disease in the photoreceptors or RPE
layers could induce secondary changes in the matrix
structure to modify the rate of visual cell degeneration.
The complexity of the 1PM and the various cell types
that border the matrix (rods, cones, RPE, and Muller
cells) precludes establishing a cell-specific association
between a given component and a cell. Similarly, the
contribution of different cell classes to the development
of the matrix is also not known. Because of the severe
developmental arrest that occurs in rcdl -affected pho
toreceptors, we have examined the matrix to see if ab-
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normalities in photoreceptor differentiation affect the
development or maintenance of the insoluble 1PM
(Mieziewska et al., 1993a). The insoluble matrix do 
mains of the 1PM are characterized using lectin cyto
chemistry (wheat germ agglutinin [WGA] and peanut
agglutinin [PNA] lectins) in cryosections of retinal tis
sues and in extracted insoluble matrix preparations, and
examined by epifluorescence and scanning confocal
laser microscopy.
In the normals, the insoluble matrix is extracted as a
continuous sheet that comprises two photoreceptor
specific matrix domains distinguished both by the size
of the domains, and by differential binding of WGA and
PNA lectins (Mieziewska et al, 1991). Each domain en
closes a photoreceptor inner and outer segment. The
PNA lectin primarily labels galactose residues in the
cone-associated matrix, with weak binding to the rod
matrix; the WGA lectin labels equally the rod- and
cone-associated matrices which contain N-acetyl glu
cosamine and sialic acid residues. The specific matrix
domains identified with these lectins are present early in
the postnatal developmental period, at the time that the
two classes of photoreceptors are recognizable cytolog
ically, and they mature in parallel with visual cell mor
phogenesis. Since the matrix conforms to the shape of
the individual rods and cones it surrounds, the struc
tural changes associated with normal photoreceptor de
velopment also occur in the matrix (Fig. 14-10A 1 2)
(Mieziewska et al., 1993a).
As noted previously, the rcdl retina shows normal de
velopment of the photoreceptors during the first two
weeks of life, and during this time period the 1PM also
develops normally. However, no change in matrix struc
ture or carbohydrate specificity is found during the pe
riod of developmental arrest (13-24 days postnatal), or
after the onset of photoreceptor degeneration (after 25
days of age; Schmidt and Aguirre, 1985). The only
changes in the 1PM that occur during this time are con
formational, i.e. distortion, adherence of cellular debris,
and loss of continuity, abnormalities that are presum
ably secondary to the severe pathology occurring in the
visual cells within the individual domains. These occur
in older affected retinas as the abnormally developed
outer segments disappear and the inner segments short
en and broaden concomitant with cell loss in the pho
toreceptor layer (Fig. 14-10B 1 _4, C1 2). Survival of cones
late in the disease is a feature of rcdl, and PNA labeled
cone domains remain intact, even when surrounding
severely degenerated cone cells (Mieziewska et al.,
1993a).
The cellular origin of the matrix constituents has not
been established (Mieziewska, 1993). Due to the close
relationship between matrix and photoreceptor cells in
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FIGURE 14-10. Optical sections normal and rcdl-affected retinas
viewed with a confocal scanning laser microscope. Sections were col
lected in 0.5 µm increments, and each picture represents one section.
Normal retina 60 days old shows the distribution of PNA (A 1 ) and
WGA (,½ ) label in both rod and cone matrices. A substructure of the
cone matrix is labeled by both PNA and WGA (arrow). The WGA ma
trix label is stronger in the OS layer than in the IS layer. In the 40-day
old rcdl-affected retina (B 1 ,3 = PNA, central [1] and peripheral [3]

retina; B2 4 = WGA, central [2] and peripheral [4] retina) the CIS ap
pear to b� displaced sclerally in relation to the small RIS. At 60 days
(Cl = PNA, C2 = WGA) substantial cell loss has occurred and the
cone inner segments are close to the OLM (arrowhead), but label
specificity is comparable to the normal retina (C 1 ). The WGA lectin
labels a domain that is irregular and distorted secondary to the rod
disease (C 2 ). Magnification X 1200. (Reprinted from Mieziewska et
al., 1993a.)

normal and diseased retinas, it is reasonable to assume
that the photoreceptor cell is synthesizing its own ma trix domain. Studies have shown that photoreceptors
are likely to synthesize chondroitin sulfate proteogly
cans which are parts of the insoluble matrix (Landers et
al., 1991). However, the close association between pho
toreceptor cells, matrix, and RPE does not preclude the
involvement of RPE in synthesis of specific matrix com-

ponents, either directly or via inductive factors. The
studies with the rcdl mutant show that normal pho
toreceptor development is not a prerequisite for the in
soluble 1PM to develop normally. Similarly, normal
maintenance of the matrix occurs even when the visual
cells are undergoing very rapid and severe degeneration,
and the matrix disappears only after there is photore
ceptor loss. It is possible, therefore, that the RPE and/or
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Muller cells are the principal cells involved in maintain
ing this elaborate and complex extracellular scaffold
once it is synthesized. Alternatively, one could argue
that the photoreceptor cells, although severely diseased,
still are able to orchestrate the formation of the insolu
ble IPM, and this structure is maintained normally un
til the visual cells disappear. These are issues that can
not be resolved at present. What is known, however, is
that the RPE plays a critical role in the remodeling and
degradation of matrix constituents through the extra
cellular and intracellular pathways involved in the
degradation of the GAG components of matrix proteo
glycans. This will be discussed in subsequent sections
(see below).
Rod-cone dyspfasia 2. A second early-onset photore
ceptor dysplasia has been identified which appears to
share many phenotypic similarities with rcd1, and, as a
result, has been given the disease designation of rod
cone dysplasia 2 (rcd2) to differentiate it from the dis
ease present in the Irish setter dogs. Based on clinical,
electrophysiological, morphological, and biochemical
criteria, the two diseases are identical (Chader, 1991;
Woodford et al., 1982). In both, there is an equally rapid
increase in retinal cGMP levels early in the postnatal pe
riod; the magnitude of this elevation, as well as its time
course, are the same (Fig. 14-8). In both rcd1 and rcd2
there also is deficient cGMP-PDE activity, although in
the latter the activity is calmodulin independent (Chad
er et al., 1985; Chader, 1991). As in rcd1, the disease is
expressed initially in the photoreceptor cells, and there
is sparing of the RPE and inner retinal layers until the
end-stages of the disease.
Although rcd1 and rcd2 are phenotypically and bio
chemically identical, there is considerable evidence that
the disorders represent mutations of different genes.
With the advent of a molecular diagnosis for rcd1, we
have established that this mutation is not present in
rcd2, and that the nucleotide sequence of exon 21 of the
PDEB gene in rcd2-affected dogs is normal (Ray et al.,
1994). This finding does not by itself rule out the PDEB
gene involvement in rcd2, as a different mutation may
be present elsewhere in the coding sequence, in an in
tron-exon junction or in the promoter or a regulatory
region. The most compelling evidence for nonidentity of
the two diseases comes from our group's previous work
in which they performed crosses between dogs affected
with rcd1 and rcd2 and found the progeny to be normal
(Acland et al., 1989). Thus rcd1 and rcd2 represent non
allelic diseases that have similar effects on retinal cyclic
GMP metabolism. It is likely, therefore, that the molec
ular defect in rcd2 resides in one of the two remaining
PDE subunits, or in the genes coding for proteins in
volved in PDE activation.
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Other photoreceptor dysplasias. Table 14-2 summa
rizes the developmental and degenerative photoreceptor
diseases of the dog. Two of these, rcd1 and rcd2 have
been discussed above. Of the three remaining diseases,
the mutant strain for one, rod dysplasia (rd), has been
lost, and the disease is no longer extant in the general
population, nor is it maintained in experimental re
search colonies (Aguirre, 1978; Acland and Aguirre,
1987). In all of these diseases there is a minimal RPE re
sponse to the degenerative process occurring in the ad
jacent photoreceptor layer (Fig. 14-11). It is only in the
late stages of the disease that the RPE undergoes atro
phy and limited intraretinal migration into areas that
are gliotic and disorganized (Fig. 14-12). These reac
tions are secondary and nonspecific. Of interest is the
exclusion of abnormalities in retinal cyclic nucleotide
metabolism as being causally associated with the dis
eases. This has been done biochemically in the case of
pd and erd (Acland et al., 1989; Parshall et al., 1991).
In the latter disease, mutations in the PDEB gene have
been excluded, respectively, by breeding and molecular
studies (Acland et al., 1989; Ray et al., 1994). This es
tablishes that abnormalities in retinal cGMP metabo
lism in the retina are not the only causes of photorecep
tor dysplasias, although they are likely to be involved in
those diseases that have an early onset and a relatively
rapid disease course.

14-11. Miiller fiber baskets (arrows) projecting through the
external limiting membrane (ELM) become prominent after loss of
photoreceptor cells in rd-affected retina. Inset shows the reduction in
photoreceptor number and the shortening of rod inner segments (RI).
The RPE is normal. Magnifications: X17,000 for main figure, X200
for inset. (Reprinted from Aguirre, 1978.)
FIGURE
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excluded the peripherin/rds, opsin, PDEB rod trans
ducin al genes from the prcd gene locus (Acland et al.,
1995; Wang et al., 1995; Ray et al., 1996; 1997). Thus,
prcd may represent a mutation of one of the other genes
or gene loci that have been identified to cause RP, or, al
ternatively, of a novel gene not previously associated
with the disease.
Photoreceptor disease and degeneration-temporal and
topographic factors. As a degenerative disease of the vi

sual cells, structural and functional abnormalities in

prcd become evident after the cells have developed nor

FIGURE 14-12.

Different stages of disease in rd illustrate the RPE re
sponse to the photoreceptor degeneration. (A) In a high-cone-density
area of the posterior pole, the loss of rods results in increased promi
nence of cones. The RPE is normal. (B) An isolated segment of RPE
and outer nuclear layer remain. (C) Focal retinal gliosis with loss of
retinal layer organization; the RPE is normal. (D) End stage atrophy.
The RPE is absent to the left of atrophic focus, but is present to the
right and has migrated intraretinally (arrow). Magnifications: (A)
X370; (B) Xl00; (C) X200; (D) X170. (Reprinted from Aguirre,
1978.)

Photoreceptor degenerations. Of the degenerative group

of hereditary retinal diseases, mutations at the prcd gene
locus account for all of the autosomal disorders recog
nized to date (Aguirre and Acland, 1988; 1991; unpub
lished). The prcd gene, as well as the different mutations
responsible for the defined allelic variants, has yet to be
identified. However, very recent studies in our lab have

mally. Pathology occurs first in th·e rod outer segments,
and progresses, with time, to involve the inner segments,
and the inner retinal layers. This highly characteristic
sequence of disease has allowed us to stage the struc
tural abnormalities into three major phases: a-disease
(stages 1 *-1); b-degeneration (stages 2-4); c-atrophy
(stages 5-8) (Fig. 14-13; Aguirre and Acland, 1988;
Long and Aguirre, 1991). Starting at approximately
12-14 weeks of age, all photoreceptor cells begin to de
velop the stage-specific pathology characteristic of the
disease, but the rate of progression is dependent on
topographic factors (Aguirre et al., 1982a). In all cases,
pathology is more severe in the inferior quadrants, while
the visual cells in the superior and temporal retinal
quadrants are spared the ravages of the disease until lat
er (Fig. 14-14). Throughout the three phases of the dis
ease, the RPE remains normal and minimally reactive
(Fig. 14-13). Only in very advanced disease will the RPE
show the nonspecific atrophic and migratory responses
illustrated in Figure 14-12D. An additional complexity
is the selectivity of the disease, at ·least initially, for rods.
Cone pathology develops late, after rods have begun to
degenerate (stage 2 and later). With loss of rods, the
cones become the predominant cell remaining in the
photoreceptor layer (Fig. 14-15).
This topographic distribution of disease is not unique
to prcd, but occurs also in other retinal degenerations,
particularly in man. The inferior retina appears to be se
lectively affected in some forms of RP regardless of the
molecular basis of the disease. Different rhodopsin mu
tations have been causally associated with RP, e.g.
Pro23His and Gly106Arg (Heckenlively et al., 1991;
Fishman et al., 1992), although not all patients with the
same molecular defect show the same regionally selec
tive damage to the inferior retina (compare Berson et al.,
1991 and Heckenlively et al., 1991). The identification
of the factors that modify the topographic expression of
the photoreceptor pathology would provide important
information on the interaction between the molecular
defect, the visual cell, and the local retinal environment,
and provide insights of the regulation of the disease phe
notype. In order to identify such factors, we have ex-
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section on "Normal Anatomy," above, the dog RPE is
not pigmented in the tapetal region (Fig. 14-1 ). Addi
tionally, the density of pigmentation is also not uniform,
with pigmentation density being greater in the periph
ery. Because of the presence of pigmented and nonpig
mented RPE regions overlying the photoreceptor mosa
ic, it is essential to consider topographic effects when
evaluating the influence of pigmentation on diseases of
the photoreceptor-RPE complex.
We have developed a technique for sampling retinal
tissues from topographically defined regions of the eye
using tissues embedded either in plastic (following glu
taraldehyde/osmium tetroxide fixation) or in diethylene
glycol distearate (DGD) wax after paraformaldehyde
fixation (Aguirre et al., 1983; 1986; Huang et al., 1993).
This permits cutting 1 µm sections which extend from
the optic disc to the ora serrata in all four quadrants; the
tissue can then be examined by conventional light mi
croscopy after staining (plastic sections), or following

14-13. Disease stages in prcd: S-0 (A), S-1 • (B), S-1 (C), S-2
(D), S-3 (E), S-4 (F), S-5 (G), S-6 (H), S-7 (I) and S-8 U). Arrowhead
(F) indicated RPE process contacting the external limiting membrane;
• (H, I, J) indicate RPE; arrow (I) indicates retinal vessel. At all stages
of the disease, the RPE remains structurally normal. Magnification
X430. (For details refer to Aguirre and Acland, 1988, from which this
figure was reprinted with permission.)
FIGURE

amined several different parameters that could be in
volved in modulating the rate and severity of the pho
toreceptor degeneration. These include: RPE pigmenta
tion (Aguirre and O'Brien, 1986), invasion of
pha-gocytic cells into the interphotoreceptor space
(Aguirre, 1986), visual cell renewal (Aguirre and
O'Brien, 1986), the soluble and insolul;lle components
of the 1PM (Wiggert et al., 1991; Mieziewska et al.,
19936), and the expression of photoreceptor-specific
proteins and transcripts (Huang et al., 1994). Thus far,
no specific properties have been identified in the inferi
or retinal quadrant that selectively predisposes this area
to earlier and more severe disease. Some of these issues
are addressed below.
Photoreceptor degeneration, RPE pigmentation and in
terphotoreceptor space phagocytic cells. As noted in the

FIGURE 14-14. Variation of prcd disease severity by quadrant. All
photographs taken 3000 µ.m from the edge of the optic disc in the su
perior (A l ' B l ' C1 ), inferior (A2, B2 ' C 2) and temporal (A3 , B 3, C3 )
quadrants of animals at 1.1 (A 1_3 ), 2.1 (B1_ 3), and 2.5 (C 1 _3) years.
Disease progresses first in the inferior quadrant; visual cells degener
ate, and macrophages (arrowhead) invade the interphotoreceptor
space. Cones (arrows) are generally spared by the disease process and
remain normal, particularly in the temporal quadrant. Magnification
X400. (Reprinted from Aguirre and Acland, 1988.)
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Right Eye

S-0
S-0-1*

s-0-1*

FIGURE 14-15. Stage 2 disease {prcd). There is extensive rod outer and
inner segment degeneration and loss which results in the increased
prominence of the cones. The RPE is normal. RN = rod nucleus, CN
= cone nucleus, ELM = external limiting membrane. Magnification
X4000. (Reprinted from Aguirre and O'Brien, 1986.)

lectin, immunocytochemical and/or in situ hybridization
procedures carried out in the same tissue. In this manner,
it is possible to correlate disease stage with any of the pa
rameters that are potentially involved in modulating the
severity of the visual cell degenerative process.
In young prcd-affected animals, the retinas show a
central-to-peripheral gradation of disease severity (Fig.
14-16). Early disease (stages -1 *, -1) is present through
out the posterior pole and equatorial regions, but stops
abruptly in the periphery where the photoreceptors be
come normal. This change in disease severity could be
associated with increasing RPE pigment density, since
a gradual change in pigmentation also occurs in a cen
tral-to-peripheral gradient. This finding raises the pos
sibility of a pigmentation associated protective effect.
However, critical examination of the areas where pig
mentation changes abruptly reveals that the change in
disease severity (from stage-1 to stage-0) is not associ
ated with a change in pigmentation. Thus, the improve
ment in disease severity appears to be dependent on
topographic position of the visual cells in the photore
ceptor mosaic rather than RPE pigmentation. With pro
gression of the disease, the peripheral sparing effect is
lost, and disease severity is of equal or greater magni
tude to that present more centrally (Fig. 14-17).
In fact, it could be argued that the presence and den
sity of RPE pigmentation per se enhances the disease
process. After all, the transition from disease (stage-1)

s-0-1*
FIGURE 14-16. Illustration of the topographic distribution of retinal
disease in the right ey e of a 22-week-old prcd-affected dog (refer to
Figure 14-13 for details of disease stages). The rectangles indicate the
exact length of the section and retinal position (refer to 3000 µ,m cal
ibration marker) in relation to the optic nerve (central circle) and ora
serrata (curved line). Rectangles above and below the optic disc rep
resent, respectively, the superior and inferior retinal quadrants; the
temporal quadrant is represented by a horizontal rectangle. The de
grees of shading within the rectangles represent the extent of RPE pig
ment density. Note that the peripheral retina is normal, but the RPE
pigmentation density does not ameliorate the severity of the disease.
(Reprinted with modification from Aguirre and O'Brien, 1986.)

to degeneration (stages-2, -3, -4) occurs first in the infe
rior retinal quadrant, a region characterized by heavy
pigmentation in the RPE monolayer (Fig. 14-17). It is
this quadrant that shows the degeneration of the pho-
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FIGURE 14-17. Comparison of the topographic distribution and pro
gression of retinal disease in both eyes of a prcd-affected dog at two
different ages (1.1 and 2.0 years). Refer to Figure 14-13 for details of
disease stages, and to Figure 14-16 for explanation of the schematic
illustration. At the earlier time period (1.1 years), the peripheral reti-

na is normal in the superior, temporal, and nasal quadrants. With
time, the disease progresses to involve the periphery. Note that disease
is more severe in the inferior quadrants, and that RPE pigmentation
does not have a protective effect. (Reprinted with modification from
Aguirre and Acland, 1988.)

toreceptors and loss of 75 %-80 % of tpe outer nuclear
layer at the time that the visual cells in other quadrants
of the eye show minimal disease. Thus, the selectivity of
the disease process for the inferior retinal quadrant can
not be explained on the basis of a protective effect of
pigmentation. These results are different from those re
ported for the RCS rat, where light deprivation or pig
mentation have a protective effect, and reduce the rate
of the retinal degeneration (LaVail and Battelle, 1975;
LaVail, 1980).

A prominent feature of the degenerative phase of the
disease is the presence of cells in the interphotoreceptor
space (Fig. 14-14B2). Initially, we suspected that these
cells represented activated RPE cells that had detached
and migrated into the interphotoreceptor space. How
ever, we found no area of the RPE monolayer that was
devoid of RPE cells, or that showed breaks in the apical
tight junctions that define the outer blood-retina barri
er. Cytological examination showed that these cells like
ly represented phagocytic rather than RPE cells, because
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14-18. Histograms correlating photoreceptor numbers (rows
of nuclei), disease stage (refer to shading key below), and number of
phagocytic cells in the interphotoreceptor space for the superior, infe
rior and temporal retinal quadrants of control and prcd-affected dogs
at 22 weeks (#1 and 2) and 36 weeks (#3) of age. In the younger af
fected dogs, disease is less severe in the periphery, the photoreceptor

number remains within normal limits, and phagocytic cells are not
present. The older affected dog (#3) shows more advanced disease (S2), especially in the inferior quadrant. Phagocytic cells are present in
the interphotoreceptor space, primarily in areas of S-2 disease.
(Reprinted with modification from Aguirre and O'Brien, 1986, and
Aguirre, 1986.)

they lacked pigmentation and had irregularly shaped,
pale nuclei with dense peripheral chromatin condensa
tion (Aguirre, 1986). Recent studies in the RCS rat in
dicate that the phagocytic cells that invade the inter
photoreceptor space are of microglial origin (Roque et
al., 1996).
We have examined the association between photore
ceptor disease and the presence of phagocytic cells in the
interphotoreceptor space. In young affected dogs, early
disease (stages 1 * and 1) is present uniformly through
out the eye, and phagocytic cells are absent. With pro
gression to stage 2, however, phagocytic cells appear

(Fig. 14-18). It is at this stage of the disease that rod in
ner and outer segments begin to degenerate rapidly, and
the number of outer nuclear layer nuclei decreases. The
histogram illustrating disease severity with the number
of phagocytic cells in the interphotoreceptor space indi
cates a direct correlation between the two processes. Al
most all the phagocytic cells that are present are re
stricted to those areas having the more severe stage-2
disease. In the late degenerative (stage-4) and atrophic
(stages-5 and -6) phases of the disease, the number of
phagocytic cells decrease (Aguirre, unpublished). This
would suggest that the debris accumulating in the inter-
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FIGURE

14-19. The central (6a-c) and peripheral (?a-cl retinal areas of
a 3 year old prcd-affected dog with stage 3 disease. (6a) WGA strong
ly labels the IPM space adjacent to the outer segments; there is diffuse
but weak labeling of the remaining IPM. The surviving photorecep
tors are well organized, except for the whorls of OS debris located on
the RPE apical surface. WGA labels the RPE cone sheaths strongly (ar
row). (6b) The PNA domain is thicker than normal, smooth and
slightly "fluffyn in appearance. (6c) The composite shows the dimin
ishing PNA label intensity at the RPE level (arrowhead). RPE lipofus-

cin granules were brightly labeled. The peripheral retina shows more
advanced stage 3 disease. (7a) WGA label is strong immediately
around the remaining cells (rods = arrowhead, cones = white arrow).
(7b) PNA label is prominent and thick around cone IS and OS (ar
row). Note that the cone matrix thickness differs when visualized with
the WGA and PNA lectins (compare Figures 14-7a and b, arrow). (7c)
The composite shows the circumference and thickness of the PNA do
main around the cones. Magnification Xl,000. (Reprinted from
Mieziewska et al., 1993b.)

photoreceptor space secondary to photoreceptor degen
eration may serve as the signal for the invasion of
macrophages.
The interphotoreceptor matrix. Using the techniques of
lectin cytochemistry, we have examined the molecular
components of the insoluble 1PM to determine if ab
normalities are present in the prcd-affected retina, either
before the development of the disease, or after the
process of photoreceptor degeneration has been initiat
ed (Mieziewska et al., 19936; Mieziewska, 1993). Be
cause of the topographic specificity for early degen
eration in the inferior quadrant, we examined for
differences between this quadrant and other retinal loci.
We reasoned that degenerative changes in the visual cells
could be initiated in response to a damaged matrix en
vironment, irrespective of the nature of the primary de
fect that is responsible for the cell dysfunction. Because
the slow degeneration present in the prcd mutant retina
allows diseased photoreceptors to remain viable for a

relatively long period of time, the microenvironment of
the 1PM during degeneration may reflect more accu
rately that present in RP, the comparable disease in man.
With the exception of the late atrophic stages (stages
5-8) of the disease, the lectin specificity remains normal
in all the ages and stages examined. However, a thick
ening of the rod and cone matrix domains is observed
in some samples representing stages 2 and 3 (Fig. 1419). Since the change in thickness was observed at a rel
atively advanced stage of degeneration, when substan
tial cell death had already occurred, the thickening may
represent a secondary response of the surviving cells.
This response would maintain the structural integrity of
the 1PM and prevent the disruption of molecular flow
through the 1PM resulting from discontinuity in the
structure. The number of photoreceptors remaining in
the 1PM compartment has been severely reduced by the
time stage 2 is reached. The extra space is presumably
occupied by broadened photoreceptors and matrix do-
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mains, as seen in later stages. Additionally, we found
that the cone domains terminated somewhat more vit
real to the RPE than normal, and, in the older affected
animals with shorter PNA cone domains, WGA (wheat
germ agglutin) strongly labeled the RPE cone sheath
surrounding these cones. The significance of this find
ing is unclear, but it could be the result of outer segment
debris accumulation below the apical surface of the
RPE. Extreme displacement of IPM material due to de
bris accumulation has been shown in the RCS rats
(LaVail et al., 1981; Porrello et al., 1986). Our findings
in the prcd mutant indicates that the photoreceptor-spe
cific IPM constituents which form the insoluble IPM are
not primarily involved in this hereditary retinal degen
eration.
Progressive Retinal Atrophy (PRAJ in the Cat
Similar hereditary retinal disorders have been recognized
in other animal species. Brief mention will be made only
of the diseases occurring in the cat, where both early
and late-onset hereditary photoreceptor degenerations
have been described. Three different early-onset disor
ders have been identified; two are dominantly inherited
(mixed-breed cats [West-Hyde and Buyukmihci, 1982]
and Abyssinians [Barnett and Curtis, 1985; Curtis et al.,
19 8 7)), and one is recessively inherited in the Persian
breed (Rubin and Lipton, 1973; Gaarder and Aguirre,
unpublished). Surprisingly, all three diseases have a very
early onset and rapid degeneration, and end-stage reti
nal disease is evident on ophthalmoscopy by the time the
animals are only a few months of age (Plates 14-V, 14VI). This is different from what is found in dogs with
the comparable developmental photoreceptor diseases
(Table 14-2). A late-onset, slowly progressive disease,
also recognized in the Abyssinian breed, is inherited as
autosomal recessive (Narfstrom, 1983). Both of the dis
eases found in the Abyssinian breed are maintained in
experimental colonies by different research groups, and
confusion may arise in those not familiar with the pro
found differences that exist between the two disorders.
Heterozygous Abyssinian cats affected with the early
onset rod-cone dysplasia (Rdy) show equal structural
abnormalities in the rod and cone pho.toreceptors (Leon
and Curtis, 1990). These remain rudimentary, and fail
to form organized outer segments; in addition, there is
delayed and incomplete photoreceptor synaptogenesis.
Degeneration begins in the central retina and progress
es to the periphery; by 30 weeks of age, two to five rows
of nuclei remain in the outer nuclear layer. In the area
centralis, the feline equivalent of the foveomacular re
gion of primates, there is atrophy of the RPE and the
choriocapillaris, and thinning of the overlying tapetal

layer. These changes are presumably secondary, as they
occur late in the disease process. Abnormalities in reti
nal cyclic nucleotide metabolism have been reported in
abstract form for the Rdy model (Leon et al., 1988), but
not published. In that brief abstract, the authors re
ported the presence of elevated retinal cGMP levels in
affected animals in the earliest stages of the dystrophy,
at a time when the cGMP-PDE activity was low.
The late-onset, recessive degenerative photoreceptor
disorder is characterized initially by disorientation of
the rod disc membranes (Narfstrom and Nilsson, 1989).
This is followed at approximately six months of age by
disintegration of the rod outer segments, appearing as
vacuolization and clumping of disc material and accu
mulation of debris. Thereafter, rod cells are lost from the
photoreceptor and outer nuclear layers. Cones develop
and remain normal until two to three years of age, at
which time degeneration begins (Narfstrom and Nils
son, 1986). In several respects, this disease has many
similarities to prcd in the dog, among which are the clin
ical, cytological, and temporal characteristics of pho
toreceptor degeneration, as well as the presence of
abnormalities in plasma lipids, particularly docosa
hexaenoic acid (22:6n-3; Anderson et al., 1991).
Retinal pigment epithelial defects have not been de
scribed in the Abyssinian cat with the late onset reces
sive disease. Based on normal rhodopsin regeneration as
determined in situ by imaging fundus reflectometry, the
normal participation by the RPE in this aspect of the
rhodopsin cycle is implied (Jacobson et al., 1989). Sim
ilarly, normal RPE function has been established elec
trophysiologically by measurements of the DC-record
ed c-wave and direct measurements of the standing
potential (Narfstrom et al., 1985). Normal dark-adapt
ed sensitivity (Narfstrom et al., 1988) and rhodopsin re
generation occur, even though a profound decrease in
IRBP gene expression has been reported at both the mes
sage and protein levels (Narfstrom et al., 1989a; Wig
gert et al., 1994). It is not clear how this finding relates
to the retinal function, or its significance in terms of the
identification of the molecular defect of the disease. To
date, only the phosducin and peripherin/rds genes have
been excluded from the disease (Gorin et al., 1993,
1995).

THE RPE IN INHERITED DEFECTS
OF LYSOSOMAL FUNCTION
Our laboratories have been involved in studies of the
RPE disease present in animals with lysosomal storage
disorders. In both man and animals, these diseases are
caused by the inherited deficiency of lysosomal en-
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zymes, and represent generalized multisystemic abnor
malities of which the ocular lesions are but one compo
nent. That selective deficiency of an enzyme results in
substrate accumulation indicates that the degradative
pathway involved, as well as the substrate accumulat
ing, are critical for the normal function of the tissue
studied. These aspects of the diseases lend themselves to
be used to define specific catabolic pathways essential
for normal RPE function. Disease in the RPE is dra
matic, and underscores the importance of the lysosomal
system in the function of this cell layer. This is not sur
prising, because compared with other tissues of the
body the RPE shows a higher activity for most of the
acid hydrolases and sulfatases (Hayasaka, 1974; Zim
merman et al., 1983; Stramm et al., 1983; Aguirre and
Stramm, 1991). Of this group of diseases, our focus has
been primarily on those disorders involved in the degra
dation of glycosaminoglycans (GAGs), known collec
tively as the inherited mucopolysaccharidoses.

Mucopolysaccharide (MPS) Storage Diseases
Severe RPE pathology with no photoreceptor disease. We
have examined the RPE in animals with mutations of
three different lysosomal enzyme gene loci: arylsulfatase
B (ASB; cat), a-L-iduronidase (a-L-id; cat) and 13-glucu
ronidase (GUSB; dog) (see Table 14-4 and Aguirre and
Stramm, 1991 for review). The lysosomal enzymes en
coded by these genes participate in the degradation of
GAGs. Morphologic studies of the three mutations in
dicate that the accumulation of intracellular inclusions
in secondary lysosomes serves as a distinct structural
marker of the enzyme deficient RPE. By light mi
croscopy, these inclusions appear vacuolated, or homo
geneous and indistinct from the surrounding cytoplasm.
Ultrastructurally, the inclusions can vary from electron
lucent to granular, lamellar, or mixed (Fig. 14-20). The
electron-lucent and granular vacuoles are believed to
represent leached and stored GAGs, respectively, while

TABLE

lamellar inclusions result from lipid accumulation sec
ondary to inhibition of ganglioside degradative path
ways by the stored GAGs (Rushton and Dawson, 1977).
Accumulation of secondary lysosomal inclusions in
the enzyme-deficient RPE is the hallmark structural ab
normality. Using the MPS-VI deficient mutant as the
prototype disease, we have found that there is RPE hy
pertrophy subsequent to the accumulation of vacuolat
ed inclusions. In the RPE, single cytoplasmic inclusions
are present initially in the early postnatal period. Their
number and size increase during the period of photore
ceptor differentiation. Subsequently, the RPE cells en
large, and the monolayer becomes uniformly hypertro
phied. In older animals, some of the enlarged cells
become massively hypertrophied, and have a uniformly
rounded apical border. These hypertrophied cells, which
can have an apical-basal height greater than 25 mi
crons, occur either singly or in clusters, and result in loss
of the uniformity that is characteristic of the RPE mono
layer (Fig. 14-21}. Similar disease is present in the MPS
VII RPE (Stramm et al., 1990). In contrast, the MPS-I
affected RPE accumulates homogeneous inclusions that
are not distinct from the surrounding cytoplasm, and
RPE hypertrophy is minimal or absent (Stramm et al.,
1989). The inclusions represent stored GAGs that accu
mulate in the diseased RPE cells (Fig. 14-22).
In spite of the severe RPE pathology, there is complete
preservation of neuroretinal structure and function. Ex
amination of the ERG rod-and-cone system responses
indicates maintenance of normal retinal function at a
time when RPE storage is severe (Aguirre et al., 1986).
Morphologic examination also shows that the internal
lamellar organization of the rod outer segments is pre
served, even though they appear disoriented when adja
cent to massively hypertrophied RPE cells. In fact, out
er segment lengths and renewal rate, an indication of the
normal participation of the RPE in the outer segment re
newal process, are normal when studied both early and
late in the disease (Fig. 14-23). It is apparent, therefore,

14-4. Lysosomal storage diseases in animal models

Number

MPS I*
MPS II
MPS IIID

Eponym

Hurler
Hunter
Sanfilippo

Animal

Cat, dog
Dog
Goat
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Enzyme

a-L-lduronidase
Iduronate-2-sulfarase
N-Acetylglucosamine
6-Sulfatase
MPSVI*
Maroteaux-Lamy
Arylsulfatase B
Cat, dog, rat
MPSVU"
Sly
Dog, mouse, cat
13-Glucuronidase
DS dermatan sulfate HS = heparan sulfate CS chondroitin sulfate
''Extensive RPE storage of substrate has been reported; refer to text for details.

Stored GAGs

DS,HS
HS,DS
HS
DS
DS,HS, CS
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chondroitin sulfates have important biological activities
in, respectively, mediating cell-to-cell interaction and be
ing an important molecular constituent of the main class
of proteoglycans present in the IPM (Stramm et al.,
1989; 1990). Of the cells bordering the interphotore
ceptor space, it is only the RPE that is involved in the
degradation of the CS component of IPM proteoglycans
(Stramm et al., 1990). Because of the severe disease that
occurs in the RPE from GUSB deficiency, it is plausible
that an equally severe abnormality would occur in the
IPM. For that reason, we have examined the matrix in
normal and mutant animals using a series of antibodies
and lectins directed at different molecular constituents of
this structure. Surprisingly, we have found only a minor
alteration in the matrix (Long et al., 1989; Long and
Aguirre, unpublished). The distribution of chondroitin
sulfate proteoglycan species (0-S, 4-S, and 6-S) is normal,
although there is a condensation of the 6-S molecular
species limited to the area of the cone matrix sheath.
Within this sheath, some of the cone outer segments
show a nonprogressive disorientation of the "coin
stack" organization of the discs. However, the major
portion of the matrix and the rod photoreceptors are
normal (Fig. 14-24). In contrast, the elegant studies of
the MPS VII mouse retina by Lazarus and colleagues
have shown that abnormalities of the IPM occur early,
and that changes in its biochemical composition or phys
ical structure may be causally associated with the subse
quent photoreceptor degeneration (Lazarus et al., 1993).

14-20. Nonpi gmemed RPE cell from the tapetal zone (arrow)
of an MPS VI-affected cat (ASB deficiency) accumulates electron lu
cent (1), granular (2), lamellar (3), and mixed (4) inclusions in sec
ondary lysosomes. The inclusions are membrane limited and distinct
from mitochondria (M). N = nucleus. Magnifications: (A) XS,700;
(B) X 19,000; (C) X 17,500. (Reprinted from Aguirre et al., 1983.)
FIGURE

that the diseased RPE cells, in spite of their massive hy
pertrophy, are still able to maintain their photoreceptor
supportive functions. Similar preservation of photore
ceptors occurs in both the MPS I (cat) and VII (dog)
models, although, in the latter, there is disorientation of
cone outer segment disc membranes (Aguirre et al.,
1986; Aguirre and Stramm, 1991). Of all the MPS mod
els reported, photoreceptor degeneration occurs only in
the MPS VII mouse (Lazarus et al., 1993).
The interphotoreceptor matrix in MPS VII. [3-glucuro
nidase, the enzyme deficient in MPS VII, is involved in
the degradation of the three principal GAGs present in
the RPE: chondroitin sulfate (CS), dermatan sulfate
(DS), and heparan sulfate (HS). Of these, heparan and

The topography of RPE disease is not uniform. The lyso
somal enzymes serve general "housekeeping" functions
in the catabolism of complex macromolecules that are
targeted to the lysosomal compartment during the re
modeling and turnover of cell membranes and extracel
lular matrices. Because of their ubiquitous distribution
in all tissues, including the RPE, and the presumably
uniform function of this cell layer in the eye, one would
expect that enzyme deficiency would result in uniform
disease expression within the monolayer. However, this
is far from the case.
In the MPS VI-deficient mutant, the number of RPE
inclusions increases with time, but this increase cannot
be considered strictly age dependent, as it is strongly
modified by topographic factors which appear to regu
late disease expression. A striking feature of the ASE-de
ficient RPE is the lack of uniformity in the expression of
the disease phenotype. This is clearly demonstrated in
Figure 14-25, which compares disease in nonpigmented
(A) and pigmented (B) RPE cells from equivalent posi
tions in the superior and inferior quadrants of the same
adult eye; the nonpigmented RPE becomes massively
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FIGURE 14-21. Nonpigmented RPE from the tapetal zone of MPS
VI-affected cats of different ages. (A) 6 months; (B) 9.5 months;
(C)-(F) 5 years. (A) vacuolated inclusions fill the cytoplasm without
causing hypertrophy. (B) the height of the RPE cells increases concur
rent with the accumulation of larger vacuoles. (C)-(F) Hypertrophy
of the RPE cells, either singly or in clusters, results in focal disarray of

the outer segment layer. Note that photoreceptor disorientation is not
accompanied by disease. Arrowheads (A) indicate a necrotic cell that
is not associated with the ASB deficiency; asterisks (C) denote normal
choriocapillaris indentation of the basal RPE. Magnifications: (A),
(B), (E), (F) X830; (C), (D) X650. (Reprinted from Aguirre et al.,
1983.)

hypertrophied while the pigmented RPE remains nor
mal. In general, two spatial gradients are present in the
ASB-deficient RPE (Aguirre et al., 1983). These are (a)
central-to-peripheral gradient within the same quad
rant: The RPE disease always is more severe in the pos
terior pole than in the periphery although, with aging,
disease in the periphery increases in· severity; and (b)
quadrant- (pigmentation-) specific distribution: The RPE
abnormality is not distributed equally about the optic
disc, but has the same disposition as that of nonpig
mented RPE cells in the superior, temporal, and nasal
meridians. That is, areas of the RPE monolayer that are
nonpigmented and over the tapetum lucidum show
marked RPE storage, while minimal-to-no storage is

present in areas where the RPE is pigmented (Fig. 1426; compare with Fig. 14-3). In older animals, the rela
tionship between RPE pigmentation and absence of dis
ease decreases in all quadrants, as progressively more
pigmented cells accumulate secondary lysosomes and
become hypertrophied. The disease phenotype, howev
er, is always less severe in the pigmented RPE.
The lack of uniformity in the response of the RPE to
an inherited lysosomal enzyme deficiency raises ques
tions concerning topographic variability in the function
and metabolism of the cell layer. It is possible that
RPE ASB enzyme activity normally is not the same
throughout the monolayer and, in the affected RPE
cells, substrate accumulates in those regions having a
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FIGURE 14-22. Scanning densitometry tracing of Alcian Blue-stained
GAGs separated by cellulose acetate electrophoresis from freshly
isolated RPE cells of a normal cat, and cats affected with MPS I (a-L
id·) and MPS VI (ASB·). The tracing of the normal RPE cell GAGs
shows three distinct peaks, the faster migrating doublet of chondroitin

sulfate/dermatan sulfate, and the slower isolated heparan sulfate peak.
In both diseases there is an accumulation of GAGs, particularly der
matan sulfate. (Reprinted with modification from Aguirre and
Stramm, 1991.)

more profound deficiency. This is not an unreasonable
hypothesis, as the activities of several lysosomal en
zymes have been shown to exhibit regional variations
(Burke and Twining, 1988; Cabral et al., 1990). Other
mechanisms that explain the milder disease phenotype
of pigmented RPE may be the presence of alternate
degradative pathways, a protective action by pigment,
or regional differences in GAG metabolism (synthesis,
secretion, and/or internalization). Recent in vitro stud
ies, discussed below, indicate that regional differences in
GAG metabolism determine the disease topography,
and that these differences are not the result of the pres
ence of the tapetum lucidum, but are dependent on the
positional origin of the RPE cells.
A lack of spatial uniformity in RPE disease expression
is also present in the MPS I feline model. However, be
cause the disease phenotype is not as dramatic as in MPS
VI (inclusions are homogeneous rather than vacuolated,
and RPE cell hypertrophy is absent), it has been more
difficult to ascertain the disease topography. As in the
MPS VI model, we have found that accumulations of
secondary lysosomes in the a-L-iduronidase-deficient

RPE occur primarily in the superior quadrant where the
RPE is not pigmented. In this area, the inclusions occu
py approximately 18 % of the cytoplasmic space. In con
trast, RPE cells from the inferior quadrant accumulate
a much smaller number of inclusions, and these occupy
no more than 5%-6% of the cytoplasmic area. With the
exception of melanin, which is not present in the supe
rior (central and equatorial) quadrant, there are no dif
ferences in the presence and distribution of other cellu
lar organelles (Stramm et al., 1989).

In vitro expression of RPE disease. Biochemical studies
on the RPE are difficult to perform; only small quanti
ties of tissue can be obtained from a single eyecup, and
the material is often contaminated by other cell types.
In vitro studies overcome these limitations by allowing
the preparation and amplification of pure populations
of RPE cells. The use of a controlled tissue culture envi
ronment allows for the precise determination of the role
of metaboliddegradative pathways in normal RPE func
tion. The in vitro systems also are amenable to studies
of the regulation of selected pathways, both at the eel-
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FIGURE

14-23. The RPE in feline MPS VI. Focal disorientation of out
er segments opposite a massively hypertrophied RPE cell (lower inset).
The internal lamellar organization of the outer segments is normal
(mai,; figure}, but the RPE cytoplasm is full of vacuolated inclusions,
and few organelles are recognizable (M = mitochondrion). Three days
after the intravitreal injection of 3H-leucine (upper inset}, a band of

silver grains is present in the autoradiogram midway along the outer
segment length in rods located opposite hypertrophied and diseased
RPE cells. This indicates that renewal is normal in spite of severe RPE
disease. Arrow in main figure indicates apical microvilli of the RPE.
Magnification: Xl0,000 for main figure; insets X850. (Reprinted
from Aguirre et al., 1986.)

lular and molecular level, and are useful for developing
methodologies for correction of the metabolic defects at
the gene level. Other chapters in this book discuss the
use of tissue culture to study RPE function and metab
olism. In this section, we address the use of in vitro
methods in the study of inherited lysosomal deficiencies
in the RPE; this topic has been reviewed previously
(Aguirre and Stramm, 1991). Of the four lysosomal
storage diseases studied in our laborato"ries (MPS I [dog
and cat], VI [cat] and VII [dog]; a-mannosidase defi
ciency [cat]), all show in vitro retention of the morpho
logic, biochemical and molecular characteristics of the
disease (Aguirre et al., 1995; Ray et al., 1996; Ray et al.,
1997; Stramm et al., 1985, 1986, 1989, 1990). Studies
presented in this section focus on the disease present in
the MPS VI cat model.

MPS VI in vitro disease. Primary cultures of RPE cells
initiated from the entire eyecup of cats with MPS VI
show that there is a profound decrease of ASB activity,
typically 5%-10% of normal (Stramm et al., 1985).
This low level, termed residual enzyme activity, is insuf
ficient to prevent the morphological manifestations of
the disease, and the MPS VI-affected cells accumulate
intracellular inclusions identical to those found in situ
(Fig. 14-27). In RPE cultures from heterozygotes, the ac
tivity of ASB is reduced to approximately 50% of nor
mal. Since these cells are phenotypically normal, both in
vitro and in vivo, it appears that this level of enzyme ac
tivity is sufficient to prevent expression of the disease.
One can conclude, therefore, that ASB activity must be
reduced below some critical level in the MPS VI RPE be
fore disease is expressed morphologically. One also may
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CHONDRO IT IN SULFATE 6-S

NORMAL

MPS VII

FIGURE 14-24. Schematic illustration of 1PM layer immunocyto- ·
chemical labeling with antibody directed against the 6-0 species of
chondroitin sulfate proteoglycan in normal and MPS VII-affected dog
retinal sections. In both there is diffuse and similar labeling through
out the 1PM. In the MPS VII retina, however, there is a condensation

also of immunoreactivity in the matrix around the cone inner and out
er segments, and intense labeling of the inclusions present in the RPE.
Note the disorientation of the cone outer segment discs, and the ex
tension of a long calyceal process. (Long and Aguirre, unpublished.)

infer from these observations that it may not be neces
sary to restore 100% of the deficient enzyme activity to
restore normal function to the diseased cells.
In a previous section, we showed that the topography
of the RPE disease in MPS VI was not uniform, and that
cells in the posterior pole exhibited massive intracellu
lar storage while those in the far periphery showed lit
tle or no accumulation of undegraded substrate. With
in the posterior pole, however, storage of undegraded
substrate was more severe in the superior than in the in
ferior regions. To examine the factors that contribute to
the region-specific distribution of RPE disease, we have
studied the in vitro RPE isolated from regionally defined
areas of the monolayer. In contrast to the isolation
method that harvests cells from the entire eyecup
(Stramm et al., 1983), regional cultures isolate cells
from topographically preselected regions by using small
glass cylinders or cloning rings to demarcate the sam-

pied area (Stramm et al., 1985; see Aguirre and Stramm,
1991 for review). A limitation of the method is that only
a small sample of cells can be harvested, but, when seed
ed at a high density, they are highly differentiated and
remain pigmented if isolated from the nontapetal re
gions of the eye.
MPS VI-topographic preservation of disease in vitro.

Regional cultures have been initiated from cells isolated
from the superior and inferior regions of the eye. We
have found that the accumulation of inclusions, repre
senting stored substrate in secondary lysosomes, occurs
primarily in cultures initiated from the posterior pole
and superior equatorial regions, and not in those initi
ated from the inferior regions or periphery (Fig. 14-28).
This region-specific in vitro disease phenotype is identi
cal to what is observed in situ, and reflects differences
in substrate accumulation that are topographically de
termined. However, disease is not the result of regional
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14-25. Sections from the tapetal (A-pigment epithelium not
pigmented) and nontapetal (B--pigment epithelium pigmented) zones
of a cat with MPS VI. As a result of arylsulfatase B deficiency, the non
pigmented RPE becomes massively hypertrophied (A) and accumu
lates cytoplasmic vacuolated inclusions. The pigmented RPE remains
normal (B). Magnification X420. (Reprinted from Aguirre et al.,
1986.)

FIGURE

differences in expression of the deficient (ASB) enzyme.
For example, cell cultures initiated from the inferior and
peripheral regions of the eye, which show no substrate
storage, have equally deficient ASB activity as cultures
from the superior regions and posterior pole, areas
which exhibit massive substrate accumulation. This is
similar to what occurs in normals, where ASB activity is
uniform, but high, throughout the monolayer (Stramm
et al., 1986).
Regional differences in RPE metabolism of GAGs deter
mine disease topography. To determine the factors that

regulate the topography of disease expression in MPS
VI, we have examined the regional metabolism of GAGs
in the RPE using an in vitro approach. The extent of ra
diolabeled GAG accumulation was dependent on the
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topographic origin of the cells. The accumulation of
GAGs within the cell layer was much greater in cultures
initiated from the superior region of the eye than in cul
tures from the inferior region (Fig. 14-29). This is in
agreement with our in vivo and in vitro morphologic re
sults (Aguirre et al., 1983; Stramm et al., 1986). In con
trast to the cell layer, the media from affected cultures
initiated from the inferior region of the eye contained
much higher levels of OS/CS than cultures from the su
perior region, and this difference in the release of new
ly synthesized GAGs into the media between regions
was sustained during the 72-hour chase period. Associ
ated with the accumulation of GAGs, there was a sig
nificant increase of collagen production in nonpigment
ed cultures from the superior quadrant (Stramm et al.,
1991).
Our studies show that the region-specific alterations
in both cell layer storage of GAGs and the release of
GAGs into the media are maintained in vitro in the pres
ence of a lysosomal enzyme deficiency that uniformly
affects both regions of the RPE. This finding indicates
that additional pathways for GAG turnover exist in the
RPE, and are more active in the less severely diseased re
gions. The alternate pathways do not appear to operate
in a regionally selective manner in normal RPE, as evi
denced by similar GAG synthesis and secretion profiles
in cultures initiated from different areas of the eye. In
the disease, however, the function of these pathways ap
pears to be selectively increased in cells derived from
specific regions of the eye. Such regionally selective
processes indicate that the RPE, although a monolayer,
must not be considered to be homogeneous in its func
tion and metabolism. This is of critical importance for
the studies of RPE diseases which are expressed in a
topographically specified site, such as AMO.
a-Mannosidosis
Our studies of the RPE in the mucopolysaccharidoses
have illustrated the importance of the lysosomal
degradative pathways for the turnover of GAGs locat
ed in the RPE cell coat, or in the extracellular matrices
that surround this cell layer (see Aguirre and Stramm,
1991 for review). Our results emphasize also that RPE
disease per se is not causally associated with visual cell
disease and neuroretinal degeneration. It could be ar
gued that lysosomal degradation of RPE GAGs, al
though important for the turnover and remodeling of
cell surface and matrix proteoglycans, is not sufficient
by itself to cause visual cell disease when a degradative
pathway is impaired by an inherited disease. However,
similar preservation of photoreceptor integrity is main-
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Right eye

MPS VI effected
11 montha of agel

temporal

FIGURE 14-26. Schematic representation of the distribution of PE dis
ease, pigmentation and the presence of the tapetum lucidum in the eye
of a young MPS VI-affected cat. For comparison with the normal see
Figure 14-3. The eye is drawn to scale based on observations of se
quential 150 µm fields extending from the disc to the ora serrata
(curved line). Note that the tapetum is present primarily in the supe
rior, nasal, and temporal meridians. The pigment epithelium is not
pigmented in areas where the tapetum is present. Disease in the pig
ment epithelium, characterized by the accumulation of vacuolated in-

clusions and cellular hypertrophy, is more severe in areas where the
cell layer is not pigmented. This is most dramatic in the superior
meridian. Key: arrows indicate the presence of tapetum; RPE pig
mentation varies from absent (empty) to moderate (density present in
the far periphery); RPE disease varies from normal (empty) to mod
erate (darker shading indicates that >5 0% of the cell volume is occu
pied by vacuolated inclusions and hypertrophy is present). (For details
refer to Aguirre et al., 1983, from which this figure was reprinted.)

tained in another lysosomal-storage disorder which is
critically involved in rhodopsin degradation.
· Acidic a-mannosidase is one of several lysosomal ex
oglycosidases which sequentially remove sugars from
the nonreducing ends of glycoproteins (see Aguirre et
al., 1986 for review of animal models of mannosidosis
and fucosidosis). Since rhodopsin is the predominant
mannose-containing glycoprotein presented to the RPE
for degradation, enzyme deficiency results in the pro
gressive accumulation of complex N-linked mannose
pentasaccharides (DeGasperi et al., 1991; Alroy et al.,
1991). The RPE disease in this mutant is far more severe

and far more rapidly progressive than in the compara
ble mutants with defects in GAG degradation. The cy
toplasm is full of secondary lysosomal inclusions, and,
other than compacted and often distorted nuclei, it is
difficult to identify cellular organelles (Fig. 14-30). In all
other respects, however, the RPE appears to function
normally. The participation of the RPE in the outer seg
ment renewal process is evident by the accumulation of
phagosomes in the apical cytoplasm, even though the
degradation of rhodopsin containing outer segment ma
terial is incomplete (Aguirre, Haskins, and Ray, unpub
lished; Aguirre et al., 1995). The outer segments are
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FIGURE 14-27. MPS VI-affected cat RPE after 14 days in tissue cul
ture retains a differentiated phenotype as well as the essential features
of the disease (compare with Figure 14-20). There is accumulation of
storage in secondary lysosomes; the inclusions appear electron lucent

(1), granular (2), lamellar (3), or mixed (4). N = nucleus, M = mito
chondria, circle = apicolateral junctions, arrowhead = culture plate.
Magnification X9,400. (Reprinted from Stramm et al., 1985.)

structurally normal, but their average length is reduced
by approximately 40%-50%. Similar changes in the
RPE have been described in cattle with hereditary a
mannosidase deficiency (Jolly et al., 1987).
The a-mannosidase-deficient mutant has a short life
span, and most animals die in their first year. It is likely
that such a severe deficiency, if sustained for years in an
animal or for decades in a human, would eventually re
sult in photoreceptor degeneration secondary to RPE
disease. What is more difficult to evaluate, however, is
the effect of a less severe but long-term change in the ac
tivity of cx-mannosidase or another RP,E lysosomal en
zyme as the result of aging (Wyszynski et al., 1989;
Boulton et al., 1994). While there may be an effect on
the RPE and neuroretina, our studies in the mutant an
imals would suggest that the effect is likely to be com
plex, and modified by other factors, both genetic and
environmental, which play a role in the aging eye. Such
issues are particularly relevant to a complex disorder
such as AMD in man, and continuing studies of the RPE
system in these animal models are crucial to clearly

defining the importance of the lysosomal degradative
pathways in the metabolic pathways of this cell layer.
Experimental Therapy of the RPE
in Lysosomal Storage Disorders

Following the in vitro demonstration that soluble "cor
rective factors" are released into the media and reverse
substrate storage in diseased cells (Fratantoni et al.,
1968), various strategies have been used to treat the
lysosomal storage disorders. Therapy has been directed
toward restoring the deficient enzyme function by en
hancing residual activity (Vine et al., 1982), by provid
ing normal enzyme directly, or, indirectly, by trans
planting bone marrow or other cells (Krivit et al., 1984;
Summers et al., 1989; Wenger et al., 1986; Haskins et al.,
1991; Akle et al., 1985). More recently, gene therapy us
ing in vivo or ex vivo correction has been accomplished
experimentally and in clinical trials. Because the disease
may be variable within and between the different clini
cal entities, and most patients show the disease pheno-
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Correction of RPE disease phenotype following bone mar
row transplantation. Our laboratories have examined
the RPE in animal models of MPS VI (cat), VII (dog),
and a-mannosidosis (cat) following successful BMT (see
Haskins et al., 1991 for review). Within each disease,
the results were consistent, but demonstrated that the
response to BMT was disease specific. This response ap
pears to be dependent on the amount of enzyme that is
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FIGURE 14-28.

MPS VI-affected cat RPE cells after 14 days in pri
mary culture. The cells were isolated from defined regions of the eye.
The top three sections are of cultures initiated from the superior equa
torial region; the three lower sections are from the inferior equatorial
region. Although the cultures have equal and deficient levels of ASB
activity, only the cells isolated from the superior region are diseased.
Magnification X800. (Reprinted from Aguirre and Stramm, 1991.)

type at the time therapy is initiated, it has been difficult
to establish criteria by which the success of therapy can
be evaluated. Determination of enzyme activity in the
serum or leukocytes provides an objective measure
ment, but one that may not be appropriate, as the as
says generally are made using artificial rather than nat
ural substrates. Consequently, the presence of normal
activity in the blood does not necessarily mean that nor
mal degradative function is occurring in the lysosomal
compartment of the other affected tissues. In collabora
tion with associates (M. Haskins and J. Wolfe) at the
University of Pennsylvania, our laboratories have ex
amined the effect of bone marrow transplantation
(BMT) on the RPE disease phenotype, and have begun
experimental gene therapy studies. These areas are dis
cussed below.
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14-29. Cell layer (A) and media (B) GAGs (dermatan sul
fate/chondroitin sulfate; DS/CS) at the end of a 72-hour period of la
beling with 35SO4• Accumulation of radio-labeled DS/CS in the RPE
is significantly elevated in MPS VI-affected (ASB·) cultures initiated
from the superior region of the eye (P < 0.02). No regional differences
are present in the normal (ASB + ) RPE. Release to the media of radio
labeled DS/CS at the end of a 72-hour labeling period is significantly
elevated in MPS VI-affected (ASB·) cultures initiated from the inferi
or region of the eye (P < 0.0005). Although not as dramatic, release
of 35 S-DS/CS also was significantly elevated in affected cultures initi
ated from the superior region of the eye (P < 0.01). No regional dif
ferences were present in the normal (ASB + ) cultures. Mean :1:SEM.
Cultures from superior (nonpigmented) region = open bars; cultures
from inferior (pigmented) regions = dark bars. (Reprinted from
Srramm et al., 1991.)
FIGURE
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FIGURE 14-30. RPE disease is severe in a young cat affected with a
mannosidase deficiency. The RPE cells are hypertrophied, and the cy
toplasm is full of vacuolated inclusions representing incompletely di
gested substrate that has been leached during tissue processing. The
RPE nucleus is indented (arrow) by the inclusions that surrounded it;
phagosomes (arrowhead) are prominently located in the RPE apical
region. Although the rod outer segments are shortened, the photore
ceptors are intact, but they accumulate inclusions in the inner segment
and perinuclear region. Magnification X 1,250. (Aguirre, Haskins and
Ray, unpublished.)

normally present extracellularly, and released by the
transplanted cells.
Even though MPS VI-affected animals have shown
improvement in some tissues after BMT (Gasper et al.,
1984 ), we have not observed any modification of the
RPE disease phenotype (Aguirre, Haskins, and Thrall,
unpublished). In these animals, the RPE cells continue
to hypertrophy as they progressively accumulate cyto
plasmic vacuolated inclusions. A similar lack of correc
tion has been found in the cornea, either following BMT
(Aguirre, unpublished) or after reciprocal corneal trans
plantation where MPS VI-affected corneal buttons were
transplanted to corneas of genetically normal animals
(Aguirre et al., 1992). In order to correct the disease in
the RPE and other tissues following BMT, the normal
enzyme has to be released from the hematopoietically
derived donor cells and has to enter the target cells by a
receptor-mediated internalization process with subse
quent targeting to the lysosomal compartment. There,
the active enzyme is able to degrade stored substrate and
prevent the subsequent GAG accumulation in the sec
ondary lysosomes. Lack of correction of the RPE disease
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could result from one or a combination of different
mechanisms: low levels of enzyme in the extracellular
compartments, failure of diffusion of enzyme from the
vascular compartment to the RPE, or failure of the af
fected RPE cells to internalize the secreted extracellular
enzyme. Based on in vitro studies of the RPE, it appears
that lack of correction results from the extremely low
availability of ASB in the extracellular compartment.
Unlike other lysosomal enzymes, ASB activity is pri
marily intracellular, with very little release to the extra
cellular compartment (Ray, unpublished).
In contrast, MPS VII-affected dogs show moderate
correction of the RPE disease phenotype after long-term
BMT. Many areas of the RPE monolayer show absence
of storage, while others show small clusters of cells with
cytoplasmic vacuolated inclusions (Fig. 14-31, B). Over
all, there is no cellular hypertrophy, and BMT results in
marked improvement of the RPE disease (Aguirre, Ray,
and Haskins, unpublished). Associated with the BMT,
there is a dramatic clearing of the cornea, and general
ized improvement of the multiorgan disease that is nor
mally present in canine MPS VII (Haskins et al., 1992).
Similar studies have been carried out in the mouse mod
el of MPS VII. Dramatic improvement of the disease phe
notype was observed in all tissues except the RPE and
retina, presumably because the high doses of irradiation
given in the perinatal period prior to BMT resulted in
complete retinal degeneration (Sands et al., 1993).
We have found that the most remarkable correction of
RPE storage occurs following BMT in the feline model
of a-mannosidosis. Eighteen months after transplanta
tion, the RPE disease is completely reversed-the cyto
plasmic inclusions disappear, cell size returns to normal,
and cellular contours are restored (Fig. 14-31, A). As a
result of the correction of the RPE disease, the photore
ceptor outer segments resume normal orientation and
elongate (Aguirre and Haskins, unpublished). As in the
MPS VII-treated animals, there is correction of the stor
age in other organs, particularly the CNS, and the severe,
progressive neurologic disease is prevented (Haskins, un
published; Walkley et al., 1994). The success of correc
tion of the RPE disease phenotype in both models prob
ably results in part from the high levels of extracellular
enzyme present following BMT. We have found that the
RPE in culture has a very high level of cellular GUSB and
a-mannosidase activity, and that it releases into the me
dia catalytically active protein (Ray et al., 1997; Ray, un
published). It is this extracellular enzyme that presum
ably is involved in the correction of disease in distant
target tissues. These studies demonstrate that RPE dis
ease can be treated by the systemic route as long as the
corrective factor being supplied to the diseased cells is
available in the extracellular environment.
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A

B
FIGURE 14-31. Improvement of RPE disease following long term
bone marrow transplantation in a cat with a-mannosidosis (A), and
a dog with MPS VII (BJ; the transplantation intervals are 2 years and
18 months, respectively. In a-mannosidosis (A), the RPE is normal and
the photoreceptors have elongated and are now of normal length
(compare with Figure 14-30). In contrast, the treated MPS VII dog still
shows some accumulation of vacuolated inclusions in the RPE, but no
hypenrophy. At this stage the RPE would show marked hypenrophy
and the cytoplasm would be full of vacuolated incwsions. Magnifica
tion X800. (Aguirre and Haskins, unpublished.)

Gene therapy of RPE disease in lysosomal storage disor
ders. The prospects of genetically altering cells and/or
organisms that have inherited defects have been im
proved by the recent advances in molecular biology. In
order to genetically engineer the cells, the foreign DNA
sequence or gene must not only be introduced into the

cell, but also needs to be expressed. Microinjection,
electroporation, and calcium phosphate (or dextran sul
fate) coprecipitation of DNA have been the traditional
methods by which foreign DNA has been transferred
into cells. However, each of these methods has inherent
limitations. In some cases, a large number of cells need
to be injected; in others, the efficiency of transfection
and/or expression is low.
The use of retroviral vectors to mediate gene transfer
has overcome many of the limitations inherent in other
methods of DNA transfer. By altering the structure of
internal retroviral sequences, these vectors lack the
polymerase and glycoprotein genes essential for replica
tion, and contain instead the foreign DNA that is to be
transferred. The deleted sequences, or trans acting func
tions, are provided by a packaging cell line which de
termines the host range and viral titers produced (Miller
and Buttimore, 1986). These retroviral vectors are in
fective but replication incompetent, and they usually re
sult in the high-efficiency transfer of the foreign DNA.
Their disadvantage, however, is that the transferred
DNA integrates randomly into the host cell chromo
somes.
For most of our studies we have used retroviral vec
tors which have internal promoters and the cDNA se
quences to be transferred (Armentano et al., 1987;
Wolfe et al., 1990) (Fig. 14-32) These vectors are de
signed to use two different promoters (the strong pro
moter from the retroviral 5' long-terminal repeat [LTR]
and an independent internal promoter) to regulate the
expression of two different genes: the neo gene and the
transferred cDNA. The neo gene confers resistance to
the neomycin analog G-418, and provides a means for
selecting in vitro those cells infected and transduced by
the retroviral vector; that is, only transduced cells will
survive when G-418 is added to the culture media. We
also have used other vectors without internal promoters
or selectable marker genes, and have found them to be
LTR>-----1 NEO

TK

Rat -Gluc cDNA

NTK-BGEO

�-�-----�

LTR1--------� PGK

hASBcDNA

PGK-hASB

FIGURE 14-32. Retroviral vectors used to mediate cDNA transfer to
the RPE. The NTK-BGO vector contains the rat 13-glucuronidase
cDNA driven by the herpes simplex thymidine kinase (TK) promoter,
and the neo gene is used for selection of the transduced cells. A simi
lar vector contains the SV-40 promoter to regulate the rat GUSB
cDNA expression (see Wolfe et al., 1990, for details). The PGK-hASB
vector has the human arylsulfatase B cDNA under the control of the
mouse phosphoglucokinase-1 {PGK) promoter, but no selectable
marker. (LTR) = long terminal repeat. (Ray et al., 1995.)
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equally effective in transferring and expressing a foreign
DNA in cultured RPE cells (Fig. 14-32).
In vitro correction RPE disease in MPS VII (dog) and
MPS VI {cat}. The rat GUSB cDNA has been transferred
in vitro to the RPE of MPS VII-affected dogs using one
of two different N2-derived retroviral vectors that con
tain the entire coding sequence of the rat GUSB cDNA
(Nishimura et al., 1986; Wolfe et al., 1990). The differ
ence between the vectors is in the internal promoter used
to drive the heterologous cDNA; these are the simian
virus 40 (SV-40) and the herpes simplex thymidine ki
nase (TK) promoters, which are cloned upstream from
the rat GUSB cDNA (Fig. 14-32). Both the SV-40 and
TK promoters are constitutive promoters with no RPE
specificity, yet the level of expression of the gene they
regulate is sufficient to correct the inherited RPE defect
(see below). It appears, therefore, that nonspecific pro
moters can be used in the RPE to regulate the expres
sion of a gene that subserves a critical degradative func
tion. Use of these vectors in high concentration (2 X 106
CFU/ml) results in high efficiency of RPE cell transduc
tion without any impairment of cellular growth, me
tabolism, or viability (Stramm et al., 1990; Wolfe et al.,
1990; Ray et al., 1992).
Following retroviral mediated GUSB cDNA transfer,
the MPS VII-affected RPE cells show complete restora
tion of GUSB activity. This represents approximately a
three- to five-hundred-fold increase in activity from the
levels measured in untreated affected cells. The effect is
specific, as the activity of other lysosomal enzymes re
mains normal and unchanged (Table 14-5; Ray, unpub
lished). These results have been confirmed in separate
experiments using RPE cells from different affected dogs
and the same vector constructs. We have found that the
GUSB activity present in the vector-treated RPE cells is
catalytically active on the natural substrate, and corrects
the block in GAG degradation. Following 72 hours of
continuous labeling with 35S04, the synthesized GAGs
retained by the cell layer of the vector-treated cells are
the same as in normal. In contrast, the untreated, af
fected cells accumulate heparan and chondroitin sul
fates (Figs. 14-33, 14-34). The restoration of normal
GAG-degradative function in the vector-treated cells oc
curs specifically in the cell layer compartment, as there
are no changes in the media GAGs to indicate increased
secretion or enhanced extracellular degradation. The lo
calization of GUSH activity in the lysosomal compart
ment of the MPS VII vector-treated cells has been
demonstrated histochemically (Wolfe et al., 1990).
Similar studies have been carried out in MPS VI cat
RPE cells having a deficiency of ASB (Ray et al., 1995).
Transduction of RPE cells was done using a retroviral
vector containing the human ASB cDNA driven by the
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14-5. Lysosornal enzyme activities in cultured
MPS VII-affected and vector-treated RPE cells

TABLE

Group

13-glucuronidase

a-L-iduronidase
(a-mannosidase)

5%*

(88%)

0.3%'"
117%

107%
103%

0.2%*
71%
102%

84%
118%

Experiment # 1

MPS VII
Experiment # 2

MPS VII
MPS V!IfTKl
Experiment # 3

MPS VII
MPS VJI/fKl
MPS VIUSV8

88%

Table reproduced from Aguirre and Strarnm, 1991 and contains
data from Wolfe et al., 1990 and Stramm et al., 1990.
Enzyme activities determined as nmol of substrate cleaved/hour/mg
protein and expressed as % of normal control values. Each deter
mination is based on four to ten different samples of three separate
experiments: Experiment I-primary cultures; Experiments 2 and
3-second passage cultures.
••Within experiment comparison between affected and normal or
treared cells, p < 0.001, t-test. TKl and SYS-cells infected with vec
tors NTK-BG-Al and NSV-BG-AB having the rat GUSB cDNA under
the control, respectively, of the thymidine kinase and SV-40 promot
ers (Wolfe et al., 1990).

mouse phosphoglucokinase-1 promoter (Fig. 14-32). In
the affected cells, the ASB activity was only 5%-10% of
normal, but, following transduction, there was a hun
dredfold increase in enzymatic activity. Restoration of
ASB activity resulted in a remarkable decrease in the
storage of dermatan sulfate, the GAG that accumulates
in the MPS VI RPE and other tissues.
In vivo correction RPE disease in the MPS VII mouse.
The MPS VII mouse model has been used extensively to
explore different treatment modalities aimed at correct
ing the lysosomal enzyme deficiency, and arresting or re
versing the pathologic sequela. Transgenic MPS VII
mice that overexpress the human GUSS cDNA in a het
erozygous manner show complete reversal of the stor
age disease (Kyle et al., 1990). Retroviral vectors also
have been used to transduce enzyme deficient hema
topoietic stem cells or fibroblasts with the normal GUSB
cDNA, followed by transplantation of these cells into
MPS VII mice. Treatment results in variable degrees of
tissue-specific correction of the disease phenotype, but
there have been no reports of the correction of the ocu
lar lesions (Wolfe et al., 1992; Marechal et al., 1993;
Moullier et al., 1993). In regards to the eye, the most
dramatic correction of the RPE disease in vivo has been
effected by the adenoviral-mediated transfer of the hu
man GUSB cDNA to ocular tissues following the in
travitreal injection of the viral vector. In short-term ex-
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FIGURE 14-33. Cell layer GAGs in normal, MPS VII-affected, and
vector-treated affected cells (MPS VII/fK-1, MPS VIUSV-8) following
a 72-hour labeling period (pulse) with 35SO4, or after a 24-hour chase.
The two vector constructs were similar except for the internal pro
moter driving the rat GUSB cDNA: TK-1 = herpes simplex thymidine
kinase promoter, SV-8 = simian virus 40 promoter (see Wolfe et al.,
1990, for details). In the MPS VII-untreated cells, newly synthesized
radio-labeled GAGs (heparan sulfate and chondroitin sulfate) accu-

mulate in the cell layer at the end of the 72-hour pulse and remain el
evated after a 24-hour chase period. In contrast, the vector-treated
cells have normal levels of GAGs in the cell layer at the two time pe
riods examined. Enzyme digestion and deamination indicates that the
increased radioactivity in the dermatan sulfate/chondroitin sulfate
peak of the MPS VII cells is only in chondroitin sulfate. (Reprinted
from Aguirre and Stramm, 1991.)

periments that lasted up to three weeks, reversal of the
RPE storage began after one week, and, by three weeks,
the MPS VII RPE was indistinguishable from normal (Li
and Davidson, 1995). It is not clear from these studies
if the adenoviral-vector-mediated cDNA transfer direct
ly corrected the affected RPE cells, or whether cells lo
cated outside the RPE-photoreceptor interface were
corrected, and secreted GUSB enzyme that diffused into
the subretinal space and cross-corrected the diseased
RPE. Another issue not established from these studies is
the duration of correction. Since adenoviral vectors do
not stably integrate into the host ce,ll's genetic material,
it is likely that long-term stability of expression will not
occur, thus necessitating repeated treatments.
These studies indicate the feasibility of using vector
mediated cDNA transfer to correct inherited defects of
the RPE. In vitro, there is high efficiency of transduction
of RPE cells, and the retroviral-vector-corrected cells
show stable and long-term expression of the transferred
cDNA (J. Ray, unpublished). In vivo, the recent studies
using adenoviral vectors are extremely encouraging,

and illustrate the possibilities of gene therapy for the
treatment of diseases of the RPE and other posterior seg
ment structures. Some of the issues of gene therapy in
the RPE have been discussed previously (Aguirre and
Stramm, 1991).

RPE UPOIDAL EPITHELIOPATHY
Aging Monkey
We and others have noted the presence of clusters of yel
low flecks and dots present in the foveomacular region
of aged rhesus monkeys that are maintained in long
term toxicologic studies (Fine and Kwapien, 1978; Bell
horn et al., 1981). These abnormalities have been de
scribed clinically as "pigmentary abnormalities of the
macula" or "lipoidal degeneration" and represent a
common aging response of the rhesus monkey RPE.
Similar lesions have been described in cynomolgus mon
keys (Feeney-Burns et al., 1981). In the rhesus monkey,
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In glutaraldehyde/osmium-fixed retinas embedded in
plastic, light microscopic abnormalities are readily ap
parent in some RPE cells located in the foveomacular re
gion. The affected cells contain light brown to dark
brown inclusions which, when numerous, completely
fill the cell. These abnormalities are extremely difficult
to detect in eyes that are conventionally fixed, embed
ded in paraffin, and sectioned at 5-6 µ,m. By electron
microscopy, the affected RPE cells accumulate intracy
toplasmic inclusions (Fine and Kwapien, 1978; Fine,
1981; Aguirre and Bellhorn, unpublished). The vacuoles
have a distinct limiting membrane, and, in most cases,
have low electron density and a homogeneous appear
ance; in some cells, the inclusions are electron lucent and
empty (Fig. 14-35). When few in number, they usually
are located basally. As their number increase, the inclu-

Migration distance (5mm/dlviaion)
FIGURE 14-34. Scanning densitometer tracings of 35SO4_labeled RPE
cell layer GAGs after continuous labeling for 72 hours or after a 24hour chase period. Each densitometer tracing represents the cell layer
GAGs of one culture of normal, MPS VII-affected, or TK 1-vector
treated affected cells (MPS VII-TKl) for each labeling period. The
markers indicate where the different GAGs run on the scan. The MPS
VII-affected RPE shows two prominent peaks of radioactivity con
sisting of HS and a DS/CS doublet. After the 24-hour chase period, the
levels of radioactivity decrease, but never approximate those of the
normal or treated cells. (Reprinted with modification from Stramm et
al., 1990.)

the lesions are found in both males and females, and ap
pear to increase in severity with aging. The mildest form
is characterized by a slight unevenness in macular pig
mentation. Later, the macula has a finely stippled or a
salt-and-pepper appearance. In the most severe form,
the foveomacular region has variable numbers of yel
lowish flecks (hypopigmented spots) which result in loss
of the foveal reflex (Bellhorn et al., 1981). Fluorescein
angiographic studies have reported conflicting findings.
One study indicates that the hypopigmented spots result
in window defects visible on angiography; the window
effect being caused by vacuolization of individual RPE
cells (Fine and Kwapien, 1978). A second study has not
been able to confirm these findings, and no association
between the location and extent of the hypopigmented
spots and angiographically visible fluorescent foci has
been established (Bellhorn et al., 1981). These foveo
macular pigmentary abnormalities cause no impairment
of function as assessed by retinal testing with elec
troretinography and visual evoked responses (Bellhorn
et al., 1981). Morphologically, the affected RPE cells
and adjacent photoreceptors remain intact (Fine and
Kwapien, 1978; Fine, 1981; Aguirre and Bellhorn, un
published).

A

B
14-35. Macular RPE of an aged rhesus monkey. Upper panel
(A) shows an RPE cell (right of vertical arrow) whose cytoplasm is full
of lipoidal inclusions of varying electron density. The cell on the left is
unaffected, and contains melanin granules and lipofuscin and melano
lipofuscin inclusions. The lower panel (B) shows that the lipoidal in
clusions are homogeneous (open star) or vacuolated(�). BM= Bruch's
membrane. Magnifications: upper panel X3,500; lower panel
XS,600. (Aguirre and Bellhorn, unpublished.)
FIGURE
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sions are located in the basal and central zones, often in
close proximity to lysosomal and/or lipofuscin granules.
The lipid origin of these inclusions has been confirmed
by using osmium tetroxide fixation for electron mi
croscopy, or glutaraldehyde fixation prior to cryosec
tioning and oil red O staining (Fine, 1981). It is likely
that these lipid inclusions have a similar origin to those
identified in the RPE of human eyes (El Baba, et al.,
1986).

Congenilol Slotionary Night Blindness {CSNBJ
in the Dog
Lipoidal epitheliopathy also has been described in the
RPE of Swedish briard dogs having congenital night
blindness (Narfstrom et al., 1994). The disease, initial
ly described as a stationary disorder analogous to hu
man CSNB, is now considered to have a progressive
component (Narfstrom et al., 19896; Wrigstad, 1994).
In general, affected dogs have an ERG of normal wave
form, but showing a marked diminution of the response
amplitudes, similar to a "Riggs-type" ERG in man. The
ERG recorded under DC conditions shows complete ab
sence of the a-, 6-, and c-waves, with the latter wave
form being replaced by a very slow negative potential
which develops when the stimulus intensity is greater
than 3 log units above the normal 6-wave threshold.
The authors interpret the abnormalities in the a- and 6waves as representing a delay in rod phototransduction,
while the lack of a c-wave was ascribed to the morpho
logic abnormalities identified in the RPE (Nilsson et al.,
1992).
Microscopic examination of the RPE showed the
presence of large inclusions in the central and midpe
ripheral tapetal regions in dogs as early as 3.5 months
of age. By light microscopy, the inclusions are single to
multiple; depending on the fixative used, they are vac
uolated or appear homogeneous and stain intensely
with crystal violet or other lipid stains (R. Riis, person
al communication, 1995). Ultrastructurally, the inclu
sions are electron lucent vacuoles with a more homoge
neous cortex which often contains membranous debris
(Wrigstad et al., 1992; 1994). Unlike the lipoidal inclu
sions found in the aging monkey R.PE, a single limiting
membrane was absent or not distinct in some of the vac
uoles. With aging, the inclusions increase in number and
are found in the peripheral RPE cells. The striking fea
ture of some of the lipid inclusions is their immense size
(Fig. 14-36).
At this time, the association between the lipoidal
changes in the RPE and the primary photoreceptor de
fect is unknown. That this interesting RPE abnormality

14-36. Nontapetal RPE of adult briard dog with congenital
stationary night blindness. Note the extremely large and homoge
neous lipid inclusion(•) present in the RPE which dwarfs the cell nu
cleus(N). The retina is artifactually detached. Magnification XS,200.
(Photograph courtesy of Dr. Ron Riis.)
FIGURE

is not an incidental finding is demonstrated by the pres
ence of similar RPE lesions in unrelated briard dogs with
CSNB, both in France and the United States. However,
the causal association between the RPE and photore
ceptor pathology is not clear. The ERG results indicate
a widespread transduction disorder of all photorecep
tors. In contrast, the RPE lipid storage, although promi
nent, is not present uniformly in all cells, and the sever
ity of the RPE pathology and photoreceptor dysfunction
are not correlated.

RPE AUTOFLUORESCENT INCLUSION EPITHELIOPATHY
Retinal Pigment Epithelial Dystrophy {RPED)
Central progressive retinal atrophy (CPRA) is a specific
pigment epithelial dystrophy recognized in several
breeds of dogs (Parry, 1954; Aguirre and Laties, 1976),
which is now termed retinal pigment epithelial dystro
phy (RPED) (Bedford, 1984). Ophthalmoscopically, the
disease is characterized by the accumulation of irregu
lar foci of light brown pigment over the tapetal zone;
with time, these foci increase in size and become dis
tributed throughout the tapetal fundus (Plate 14-VII). In
the end stages of the disease, the pigmentation decreas
es or forms clusters around the margins of foci of reti
nal atrophy.
Using conventional histologic methods, the earliest
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FIGURE 14-37. Retinal pigment epithelial dystrophy (RPED) in the
dog. (A) In the early stages of the disease, there is focal hypertrophy
of the RPE (arrowhead) with accumulation of granular light brown
material in the cytoplasm. (B) This material is intensely autofluores
cent (white arrow). Note that the rest of the RPE layer is normal. (C)
With time, more cells in the monolayer become diseased (white ar
rowheads). Opposite the hypertrophied cells, the photoreceptor inner
and outer segments are disoriented and compressed. The outer and in
ner nuclear layers (ONL and INL) show normal levels of autofluo
rescence for fixed tissues. Magnifications: (A) and (B) X280; (C)
x225.

recognizable lesion is in the RPE. Individual cells be
come hypertrophied and accumulate a light brown
granular material in the cytoplasm. Opposite the hy
pertrophied cells, the photoreceptor outer segments are
shortened. Gradually, the focal lesion spreads in the
RPE monolayer, and more cells become hypertrophied
(Fig. 14-37). In the end stages of the disease, the hyper
trophied RPE cells form multicellular cell nests; at this
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time, there is focal degeneration of the photoreceptors
followed by complete retinal degeneration with in
traretinal migration of non-melanin-containing cells.
Fluorescent microscopy of unstained retinal sections in
dicates that the diseased RPE cells, either located on
Bruch's membrane or migrating intraretinally, contain a
bright autofluorescent lipopigment similar to ceroid or
lipofuscin (Fig. 14-37B, C). Recent studies reported in
abstract form suggest that the pigments that accumulate
in the disease vary by breed, and differ from those that
accumulate in the aging human RPE in that they are the
result of peroxidation of rod outer segment lipids (Wat
son and Bedford, 1992; P. Watson, personal communi
cation, 1993 ).
Most current studies of RPED have been carried out
in the briard dog breed in the United Kingdom (Bedford,
1984; Lightfoot, 1988) (Note that RPED differs from
the CSNB, which also is reported in briards.). These
have demonstrated that rod outer segment renewal is
normal, as is acid phosphatase activity in the RPE. In
contrast, affected dogs are hypercholesterolemic and
systemically deficient in vitamin E and taurine (P. Bed
ford, personal communication, 1996; Watson et al.,
1993).
The clinical and histologic features of RPED are sim
ilar to vitamin E deficiency retinopathy in dogs, either
naturally acquired (Hayes et al., 1970) or produced ex
perimentally (Riis et al., 1981). In all three diseases, the
RPE cells become hypertrophied and accumulate lipo
fuscin inclusions. In the experimental deficiency, how
ever, lipofuscin accumulation and RPE hypertrophy oc
cur after there is the beginning of photoreceptor outer
segment degeneration visible by electron microscopy,
and the disease course is much more rapid (Riis et al.,
1981). This suggests that the target cell for the disease
may be the photoreceptor, even though the most dra
matic manifestation of the disease is in the RPE.
The similarities between RPED and vitamin E defi
ciency may explain its unique geographic distribution.
The disease was once prevalent in the United States, but
now is extremely rare, and only sporadic cases are iden
tified. In Western Europe, particularly the United King
dom, by contrast, the disease has had a very high preva
lence until recently, and many breeds of dogs have been
affected. Because of the possibility that RPED is associ
ated with antioxidant deficiency, the disease frequency
in young dogs has been markedly reduced with the
widespread use of vitamin E supplementation (P. Bed
ford, personal communication, 1996). It is not clear at
this time, however, whether the disease represents a
strictly nutritional deficiency, or is an inherited defect
that becomes manifested clinically by inadequate diets.
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Equine Motor Neuron Disease (EMND)
A spontaneous neuronopathy has been recently identi
fied in adult horses which bears a striking resemblance
to the sporadic f orm of amyotrophic lateral sclerosis of
man (Cummings et al., 1990). The disease is a progres
sive degeneration of motor neurons of the spinal cord
and brainstem which results in muscle atrophy, weak
ness, and wasting; it is generally fatal. Studies have sug
gested an association between vitamin E deficiency and
EMND, since affected animals have been found to have
marked decreases in plasma vitamin E levels (Divers et
al., 1994), and they have demonstrated ceroid lipopig
ment accumulation in the endothelial cells of small ves
sels in the spinal cord (Cummings et al., 1995).
Characteristic lesions of the RPE have been found in
most animals with clinical abnormalities indicative of
EMND; in all cases, the ocular abnormalities have al
ways been found in association with the neurologic dis
ease. Fundus examination reveals a horizontal linear or
mosaic pattern of pigmentation, located either close to
the optic disc or throughout the fundus. These lesions
are bilateral, but may vary in severity between the two
eyes (Riis et al., 1995). The fundus abnormalities are
the result of accumulation of an autofluorescent lipopig
ment within hypertrophied RPE cells. Initially, the
hypertrophied cells occur in foci with no apparent
photoreceptor disease. Later, there is degeneration of
the photoreceptor cells and inner retinal layers, and
macrophages accumulate in the interphotoreceptor
space and migrate intraretinally. Autofluorescent lipo
pigments are found in the hypertrophied RPE and in
macrophages. By electron microscopy, the RPE lipopig
ments are typical of lipofuscin and ceroid (Fig. 14-38)
(Cummings et al., in press; R. Riis, personal communi
cation, 1995)

Neuronal Ceroid Lipofuscinosis (NCL)
The neuronal ceroid lipofuscinoses in man are a group
of diseases divided into distinct syndromes based on
clinical and pathologic criteria; in general, four syn
dromes have been recognized (infantile, late infantile,
juvenile, and adult), and each has a complex of epo
nyms. Although the diseases have a broad spectrum of
neurologic abnormalities, the common denominator is
the accumulation of autofluorescent lipopigments in
neurons and other cells (Jolly and Palmer, 1995). Except
for the infantile form of the disease, which is caused by
mutations in the palmitoyl protein thioesterase gene, the
molecular basis of NCL is unknown (Vesa et al., 1995).
The same diversity of clinical disease and ocular abnor
malities also occurs in animals with NCL (Aguirre et al.,

14-38. RPE cell from horse affected with equine motor neu
ron disease (EMND). Melanin granules and numerous lipofuscin (ar
rowhead) and ceroid (open arrow) inclusions are present in the cyto
plasm. Magnification X8500. (Photograph courtesy of Drs. R. Riis
and J. Cummings.)

FIGURE

1986; Jolly and Palmer, 1995; Jolly et al., 1994). A com
mon clinical manifestation in both man and animals is
the presence of blindness, which occurs at approxi
mately the same time as the clinical syndrome with
which it is associated. With some exceptions (see be
low), the blindness is cortical in origin, since photore
ceptor structure and function generally are preserved.
In sheep, an early adult onset, acute form of NCL has
been described. Animals develop normally for several
months after birth, and then show progressive neuro
logic abnormalities, visual deficits, and blindness; death
occurs by approximately two years of age. Blindness in
sheep is the result of a progressive degeneration of the
photoreceptor cells, particularly the rods. In affected an
imals, there is a marked loss of rod-mediated ERG re
sponses until they disappear soon after one year of age;
cone responses, on the other hand, remain normal until
that time and decay thereafter. These functional abnor
malities are reflected in the pathology of the retina,
which demonstrates a progressive rod-cone degen
erative process. The RPE remains relatively normal

�
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throughout the disease, but accumulates numerous elec
tron-dense membranous cytoplasmic structures which
are autofluorescent. However, these inclusions are
smaller and less numerous than elsewhere in the retina
(Graydon and Jolly, 1984). Additionally, RPE function,
as determined by the response to azide, remains normal
even in blind, terminal animals (R. Jolly, personal com
munication, 1984). Extensive photoreceptor degenera
tion with preservation of the RPE also has been found
in Devon cattle with NCL (Jolly et al., 1992).
In contrast, most canine forms of NCL are distin
guished by blindness of nonretinal origin (see Jolly et al.,
1994 for review). Of these, the best characterized dis
ease is that found in the English setter which has an ear
ly adult onset with an acute course (see Koppang, 1992
for review). In this breed, retinal function is initially
normal at a time when neurologic abnormalities are
present. Thereafter, ERG responses become reduced
(Berson and Watson, 1980; Aguirre et al., 1986), and,
in the very late stages of the disease, the DC recorded
ERG shows a severe depression of the responses. At this
time, there is a decrease in amplitude and eventual dis
appearance of the ERG c-wave, and a reduction in the
standing potential (Nilsson et al., 1983 ). These findings
suggest an impairment of RPE function.
Retinal abnormalities associated with NCL have been
reported in the Tibetan terrier (Riis et al., 1992), minia
ture schnauzer (Smith et al., 1996) and Polish Owczarek
Nizinny (Wrigstad et al., 1995) dog breeds. In Tibetan
terriers night blindness is the primary clinical abnor
mality recognized in young animals. In contrast, NCL
in the Nizinny breed appears clinically similar to RPED,
and the fundus shows the accumulation of irregular foci
of light brown pigment over the tapetal zone which,
histologically, reflects the storage of autofluorescent
lipopigments in hypertrophied RPE cells . In these three
breeds, the clinical manifestations of NCL are initially
retinal (photoreceptor or RPE), with neurological ab
normalities occurring later in life.
As in humans and other animal models of NCL,
autofluorescent lipopigment inclusions accumulate in
the RPE cells and other retinal and CNS neurons of af
fected English setter dogs. However, the association be
tween neuronal lipopigment storage and cell death is
not known. Since there is no degeneration of the retina
or RPE cells in many different animals with this disease,
even though significant storage is present (Neville et al.,
1980), the causal association between lipopigment stor
age, cell dysfunction, and cell death is not clear at this
time. This will require identification of the molecular
defects present in these different diseases, and charac
terization of the biochemical abnormalities resulting
from the gene defect(s).
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MACULAR ABNORMALITIES AND DRUSEN
IN MONKEYS
Macular degeneration is uncommon in the subhuman
primate. With few exceptions, abnormalities of the mac
ula occur sporadically, and are reported as single case
studies. Attempts to determine if macular degeneration
occurs naturally in primates have resulted in surveys of
monkey colonies (Stafford, 1974; El-Mofty et al., 1978;
Nicolas et al., 1996), the most extensive of these under
taken at the Cayo Santiago colony, a part of the
Caribbean Primate Center (EI-Mofty et al., 1978; 1980;
Engel et al., 1988; Dawson et al., 1989). In their initial
survey, El-Mofty and colleagues (1978) reported two
types of macular anomalies which were age related and
affected approximately half of the 105 animals exam
ined: (a) a macular pigmentary disorder showing various
degrees of irregularity in the distribution and intensity of
pigmentation, and (b) multiple discrete small white spots
that mainly clustered in the paramacular area. The pig
mentary abnormalities probably are the lipoidal epithe
liopathy described in a preceding section, while the para
macular white spots were interpreted by the authors as
drusen. A repeat study of a larger group of animals con
firmed the previous observations and found that over
80% of old animals had macular lesions (El-Mofty et al.,
1980). However, some young animals one to three years
of age also showed similar lesions of equal severity, sug
gesting a heritable component to the disorder. A separate
and independent survey of this colony has been under
taken, and confirmed the presence of macular drusen
which, histologically, are nearly identical to similar le
sions found in the human eye. Although this limited sam
ple did not show any animals with the exudative form of
AMD or disciform scars (Engels et al., 1988), a larger
sampling reported older animals with end-stage disci
form changes (Dawson et al., 1989).
In a study by Feeney-Burns and colleagues (1981), the
authors examined the retinas of cynomolgus monkeys
with macular abnormalities visible by ophthalmoscopy
or fluorescein angiography. Lipoidal epitheliopathy,
misshapen foveal depressions, RPE depigmentation,
and exudative foci underneath the RPE were found. Sur
prisingly, morphologic examination of the macular re
gion of animals considered clinically normal showed
retinal pathology limited to the macular region. These
consisted of degeneration of parafoveal cones, balloon
ing and disarray of foveolar cone outer segment disc
membranes, and accumulation of lamellar, osmiophilic
material in the inner and outer segments. The authors
emphasized the importance of thoroughly characteriz
ing the normalcy of primate populations before their use
in experimental studies.
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Drusen have been reported in monkeys, either limit
ed to the macular region, or uniformly distributed
throughout the fundus (Barnett et al., 1972; Stafford,
1974; El-Mofty et al., 1980; Ishibashi et al., 1986). The
histologic appearance of the lesions is quite characteris
tic, and similar to comparable abnormalities in man. As
noted previously, the incidence of macular and para
macular druse increases with aging. Generalized drusen
of the fundus have been found in baboons and rhesus
monkeys, usually at a young age, suggesting that these
lesions may be present congenitally or develop in the
perinatal period. They occur as large, single or multiple
nodules which are overlaid by an extremely thin and at
tenuated RPE. Other than disorientation of the apposed
photoreceptor cells, there is surprisingly minimal patho
logy of the retina (Barnett et al., 1972; Aguirre, unpub
lished).
A bilateral macular degeneration associated with
widespread outer retinal disease has been reported in a
colony of captive reared Guinea baboons (Vainisi et al.,
1974). In the propositus, the maculae were atrophic,
with a reticular yellow metallic appearance, and promi
nent window defects were evident on angiography
(Plate 14-VIII). The RPE and retina were absent in the
macular region; more peripherally, there was photore
ceptor degeneration with RPE preservation. Additional
studies on animals from this colony have shown that the
disease is likely to be hereditary, but the mode of inher
itance has not been established. In young animals, the
initial clinical abnormalities are restricted to the macu
la (subtle depigmentation in the fovea surrounded by a
hyperpigmented ring); histologically, the RPE is normal,
but disease is present in the photoreceptors and is more
widespread. There is initially degeneration of parafoveal
rods and cones which subsequently spreads to involve
those photoreceptors in the equator and periphery. In
animals with advanced macular degeneration, there is
extensive degeneration and loss of the photoreceptor
and outer nuclear layers in the equator and periphery
(Tso et al., 1983; Santos-Anderson et al., 1983). Unfor
tunately, a colony of this potentially important animal
model for human retinal disease is no longer extant.

ORNITHINE-6-AMINO TRANSFERASE
DEFICIENCY IN CATS
Deficiency of the mitochondrial matrix enzyme or
nithine-8-amino transferase (OAT) causes a retinal de
generation in man and cats. In man, the disease is
termed gyrate atrophy ofthe choroid and retina because
of the characteristic fundus lesions. In contrast, cats
with OAT deficiency have a generalized retinal degen-

eration (Plate 14-IX) that is clinically indistinguishable
from that present in animals affected with PRA, the
group of primary photoreceptor degenerative diseases.
In cats the disease has been found sporadically, and is
characterized by hundredfold elevation in plasma or
nithine levels with overflow ornithinuria (Valle et al.,
1981; 1983; Rosenzweig et al., 1990). This results from
deficiency of OAT in tissues, and enzyme deficiency is
confirmed in cultured fibroblasts. A suggestion of auto
somal recessive inheritance is based on the finding that
presumably heterozygous animals have reduced OAT
activity levels that are intermediate between affected
and normal cats (Giger, personal communication,
1995). In one animal, OAT was pyridoxine responsive,
but long-term oral supplementation with this vitamin
did not affect the progression of retinal degeneration
(Aguirre, unpublished). Histologic examination of the
retina shows complete atrophy of the RPE and pho
toreceptor cells, and end-stage retinal degeneration (Fig.

FIGURE 14-39. Light (A and B) and electron (C) micrographs of the
tapetal retina from an adult cat with ornithine-6-amino transferase de
ficiency. (A) Retina in the posterior pole shows loss of RPE and pho
toreceptor layers, with preservation of inner retina (INL, IPL, NFL).
(B) Tapetal region (TL) showing a very thin and gliotic retina with a
prominent ganglion cell. (C) Unidentified neuron (N) surrounded by
prominent glial fibers (G) is located adjacent to the tapetum lucidum
(TL). Magnifications: (A) and (B) X400, (C) X9,600. (Reprinted from
Valle et al., 1981.)
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14-39) (Valle et al., 1981). Such extensive atrophy of the
outer retina is unusual for retinal-degenerative disorders
in cats or other animals.

299

Subretinal displacement of photoreceptor nuclei has
been found in many different animal species. In the rat,
the displacement reflects a general mechanism of cell
loss that is influenced, to some extent, by aging and en
vironmental exposure to high ambient light intensities
(Lai et al., 1978; Lai 1980). A similar process occurs in
humans and has been associated with age-related de
generative disorders of the eye, diabetes, or systemic in
fections (Lai et al., 1982). In most cases, the distinct cy
tologic characteristics of the photoreceptor nuclei help
to distinguish them from the phagocytic cells that in
vade the subretinal space during the degenerative phase
of primary photoreceptor diseases (see "PhotoreceJ?tOr
degeneration, RPE pigmentation, and interphotorecep
tor space phagocytic cells," above).
The presence of ectopically located photoreceptor nu
clei in the subretinal space is supposed to represent two

different cell death mechanisms: in situ death followed
by displacement, and the outward movement of pho
toreceptors with their subsequent death in the subreti
nal space (Lai et al., 1982). Recent studies in dogs with
inherited cone degeneration question the loss of viabili
ty of the ectopically located photoreceptor cell nuclei,
particularly cones (Gropp et al., 1996).
We have previously identified a canine model for rod
monochromatism in man (Aguirre and Rubin, 1974;
1975). The disease was initially termed hemeralopia,
but, in order to prevent etymological controversy, the
name and gene locus identification were changed to
cone degeneration (Long and Aguirre, 1991). Cone de
generation (cd) is a rare, autosomal recessive disorder
found originally in the Alaskan malamute breed, and
characterized by specific functional and structural ab
normalities limited to the cone photoreceptors. The dis
ease is unique in being the only model for selective cone
degeneration in man. In the cd retina, cones become dys
functional early in life, show disorganization and loss of
outer segments, and accumulate 100 A neurofilament
bundles in the inner segment and perinuclear cytoplasm;
degeneration of cones occurs subsequently.
An unusual feature of cd is the manner in which cone

14-40. Ectopically located cone nucleus (CN) adjacent to the
retinal pigment epithelium (PE) in an adult dog with hereditary cone
degeneration (cd). The ectopic nucleus is surrounded by a rim of cy
toplasm, and indents the apical border of the PE, bringing the apical
ly located melanin granules closer to the basal PE surface and Bruch's

membrane (BM). The ectopic nucleus is surrounded by the apical mi
crovilli of the PE {open arrows). Note the distinct separation between
the cytoplasmic membranes of the PE and the ectopic cone nucleus
(black/white arrows). Magnification X 10,500. (Reprinted from
Gropp et al., 1996.)

THE RPE AND ECTOPIC PHOTORECEPTOR NUCLEI

FIGURE

300

INHERITED AND METABOLIC DISORDERS

14-41. Paired PNA fluorescence and Nomarski (A, C and B,
D) photomicrographs of the cd retina from an adult affected dog.
Groups of PNA-positive cone somata are clustered ectopically in the
subretinal space (A) (open arrow). Some cells extend PNA positive
processes (B) (arrow) proximally to the external limiting membrane
(marked by arrowheads in C and D). Distinct cone matrix sheaths are
still present (A) (arrow). Artefactual detachment of the retinal pigment
epithelial layer accentuates the ectopically located cone nuclei. Mag
nifications: (A) and (C) X250; (B) and (D) X750. (Reprinted from
Long and Aguirre, 1991.)
FIGURE

loss evolves. Unlike other models of photoreceptor de
generation, where nuclear pyknosis and apoptotic cell
death follow disease and degeneration of the outer and
inner segments (Chang et al., 1993; Portera-Cailliau et
al., 1994), this process does not occur, at least initially,
in the cd retina. Diseased cones undergo slow extrusion
of the nucleus into the inner segment, displacement into
the interphotoreceptor space, and final placement adja
cent to the RPE (Fig. 14-40). In this position, the ec
topically located nuclei indent the RPE surface, but
cause no further response (Gropp et al., 1996). Cone ex
trusion also occurs in complete typical rod monochro
matism in man, the disease for which cd serves as an an
imal model (Larsen, 1921; Harrison et al., 1960; Falls
et al., 1965). In the retinas of humans affected with this
disorder, there is loss of cones as well as the presence of
ectopic cone nuclei which are located in the inner seg
ment, in the interphotoreceptor space, and adjacent to
the RPE (Falls et al., 1965).
Examination of cd-affected retinas embedded in plas
tic and sectioned at 1 µm suggests that the ectopic cone

14-42. Brightfield (A i, B1 ) and combined brightfield/epipo
larization (B2) photomicrographs of the cd retina from a young af
fected dog hybridized with 3H-labeled antisense human red/green
cone opsin cRNA probe. The ectopically located cone nuclei (arrow
heads) are located adjacent to the retinal pigment epithelium (A1 , •;
see B1 for higher magnification), and have an accumulation of silver
grains in the perinuclear cytoplasm. The remaining cones in the pho
toreceptor layer (arrows, A i, B1) have silver grains that cluster in the
perinuclear cytoplasm or the proximal inner segment. The intensity of
the hybridization signal in all cones is normal. Magnifications: (A 1)
X800; (B 1 ) and (B2) Xl000. (Reprinted from Gropp et al., 1996.)
FIGURE
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nuclei are separated from the photoreceptor layer. How
ever, in thicker sections (10 µm) reacted with peanut ag
glutinin (PNA) lectin to identify the extracellular cone
matrix domains, some of the subretinal nuclei appear to
be connected to the external limiting membrane, and, in
some cases, form cellular aggregates in the subretinal
space (Fig. 14-41-Long and Aguirre, 1991). Addition
ally, in situ hybridization using a red/green cone pigment
cRNA probe indicates normal cone opsin gene expres
sion (Fig. 14-4 2). Based on the presence of cone pigment
mRNA transcripts, and immunoreactivity (using cone
specific antibodies) of intensity equal to that found in
normally placed cone cells, we consider these ectopic
cone nuclei viable (Gropp et al., 1996). With aging,
there is progressive loss of cone nuclei from their nor
mal position in the photoreceptor layer, and the oldest
retina examined had the greatest number of ectopic
cone nuclei located at the level of the RPE. Whether the
ectopically located cone nuclei eventually degenerate or
remain viable is not known at this time. However, their
position adjacent to the RPE monolayer fails to elicit
any histologically evident cellular response.
A C KN OW L E D G M EN T S
The studies presented in this chapter have been supported in part
by NIH grants EY-01244, -06855, -07705 and -11,142, DK-25759
andNS-33526, The Foundation Fighting Blindness, The Morris Ani
mal Foundation, The Seeing Eye, Inc., the American Federation for
Aging Research and the Starr Foundation.
R EF E R EN C E S
A.eland GM, Aguirre GD. 1987. Retinal degenerations in the dog: IV.
Early retinal degeneration (erd) inNorwegian elkhounds. Exp Eye
Res 44:491-521.
A.eland GM, Ray K, Aguirre GD. 1995. Exclusion of the cyclic GMP
PDE beta subunit gene as a candidate in the prcd-dog. Invest Oph
thalmol Vis Sci 36:S891.
A.eland G, Fletcher RT, Gentleman S, Chader G, Aguirre G. 1989.
Non-allelism of three genes (red 1, red 2 and erd) for early-onset
hereditary retinal degeneration. Exp Eye Res 49:983-998.
A.eland G, Blanton SH, Hershfield B, Aguirre G. 1994. XLPRA: A ca
nine retinal degeneration inherited as an x-linked trait. Am .J Med
Gen 52:27-33.
Aguirre GD.1978. Retinal degenerations in the dog. L Rod dysplasia.
Exp Eye Res 26:233-253.
Aguirre G. 1986. Phagocytic cells in the interphatoreceptor space: cor
relation with disease stage in canine progressive rod-cone degener
ation. In: Agardh E, Ehinger B, eds, Retinal Signal Systems, Degen
erations and Transplants. New York: Elsevier, 193-200.
Aguirre GD, A.eland GM. 1988. Variation in retinal degeneration phe
notype inherited at the prcd locus. Exp Eye Res 46:663-687.
Aguirre G, Acland G. 1991. Inherited retinal degeneration in rhe
Labrador retriever dog. a new animal model of RP? Invest Oph
thalmol Vis Sci 32(Suppl):889.
Aguirre GD, Laties A. 1976. Pigment epithelial dystrophy in the dog.
Exp Eye Res 23:247-256.

301

Aguirre G, O'Brien P. 1986. Morphological and biochemical studies
of canine progressive rod-cone degeneration: 3H-fucose autoradi
ography. Invest Ophthal Vis Sci 27:635-655.
Aguirre GD, Rubio LF. 1974. Pathology of hemeralopia in the
Alaskan malamute dog. Invest Ophthalmol 13:231-235.
Aguirre GD, Rubin LF. 1975. The electroretinogram in dogs with in
herited cone degeneration. Invest Ophthalmol 14:840-847.
Aguirre GD, Rubin LF. 1979. Diseases of the retinal pigment epithe
lium in animals. In: Zinn K, Marmor M, eds, The Retinal Pigment
Epithelium. Cambridge (MA): Harvard University Press; 334-356.
Aguirre G, Stramm L. 1991. The RPE: a model system for disease ex
pression and disease correction. Prog Retinal Res 11:153-191.
Aguirre GD, Lolley R, Farber D, Fletcher T, Chader G. 1978. Rod
cone dysplasia in Irish setter dogs: a defect in cyclic GMP metabo
lism in visual cells. Science 201:1133-1134.
Aguirre G, Alligood J, O'Brien P, BuyukmihciN. 1982a. Pathogene
sis of progressive rod-cone degeneration in miniature poodles. In
vest Ophthal Vis Sci 23:610-630.
Aguirre G, Farber D, Lolley R, O'Brien P, Alligood J, Fletcher RT,
Chader G. 1982b. Retinal degenerations in the dog: III. Abnormal
cyclic nucleotide metabolism in rod-cone dysplasia. Exp Eye Res
35:625-642.
Aguirre G, Stramm L, Haskins, M. 1983. Feline mucopolysacchari
dosis: VI. General ocular and pigment epithelial pathology. Invest
Ophthal Vis Sci 24:991-1007.
Aguirre G, Stramm L, Haskins M, Jezyk P. 1986. Animal models of
metabolic eye disease. In: Renie W, Goldberg M, eds, Goldberg's
Genetic and Metabolic Eye Disease. Boston: Little, Brown
139-167.
Aguirre G, Raber I, Yanoff M, Haskins M. 1992. Reciprocal corneal
transplantation fails to correct mucopolysaccharidosis VI corneal
storage. Invest Ophthalm Vis Sci 33:2702-2713.
Aguirre G, Ray J, Pearce-Kelling S, Stramm L, Haskins M. 1995.
Lysosomal a-mannosidase is essential for retinal pigment (RPE) de
gra-dative function. Invest Ophthal Vis Sci 36:S816.
Akle C, McColl I, Dean M, Adinolfi M, Brown S, Fensom A, Marsh
.J, Welsh K. 1985. Transplantation of amniotic epithelial mem
branes in patients with mucopolysaccharidoses. Exp! Clin Im
munogenet 2:43.
Akhmedov NB, Piriev NI, Ray K, A.eland, GM, Aguirre GD, Farber
DB. 1997. Structure and analysis of transducin 133-subunit, a can
didate for inherited cone degeneration (cd) in the dog. Gene
194:47-56.
Alroy J, Bachrach A Jr, Thalhammer JC, PanjwaniN, Richard R, De
Gasperi R, Warren CD. 1991. Clinical, neurophysiological bio
chemical and morphological features of eyes in Persian cats with
mannosidosis. Virchows Archiv B Cell Pathol 60:173-180.
Anderson R, Maude M, Alvarez R,Nilsson SE,Narfstrom K, A.eland
G, Aguirre G. 1991. Plasma lipid abnormalities in prcd-affected
miniature poodles and Abyssinian cats. In: Hollyfield JG, Ander
son RE, Lavail MM, eds, Degenerative Retinal Disorders: Clinical
and Laboratory Investigations. Boca Raton, Fla.:CRC Press,
131-142.
Armentano D, Yu S-F, Kantoff PW, von Ruden T, Anderson WF,
Gilboa E. 1987. Effect of internal viral sequences on the utility of
retroviral vectors. J Virol 61:1647-1650.
Barbehenn E, Gagnon C,Noelker D, Aguirre G, Chader G. 1988. In
herited rod-cone dysplasia: abnormal distribution of cyclic GMP in
visual cells of affected Irish setters. Exp Eye Res 46:149-159.
Barnett KC, Curtis R. 1985. Autosomal dominant progressive retinal
atrophy in Abyssinian cats. J Hered 76:168-170.
Barnett KC, Heywood R, Hague P. 1972. Colloid degeneration of the
retina in a baboon. J Comp Pathol 82:117-118.

302

INHERITED AND METABOLIC DISORDERS

Bedford PGC. 1984. Retinal pigment epithelial dystrophy (CPRA): a
study of the disease in the briard. J Small Anim Pract 25:129-138.
Bellairs R, Harkness LR, Harkness RD. 1975. The structure of the
tapetum in the eye of the sheep. Cell Tiss Res 157:73.
Bellhorn RW, Bellhorn MB, Swarm RL, Impellizzeri CW. 1975.
Hereditary tapetal abnormality in the beagle. Ophthal Res 7:250260.
Bellhorn RW, King CD, Aguirre GD, Ripps H, Siegel IM, Tsai HC.
1981. Pigmentary abnormalities of the macula in rhesus monkeys:
clinical observations. Invest Ophthalmol Vis Sci 21(6):771-781.
Bernstein MH, Pease DC. 1959. Electron microscopy of the tapetum
lucidum of the cat. .I Biophys Biochem Cyrol 5:35-53.
Berson EL, Rosner B,Sandberg MA, Dryja TP. 1991. Ocular findings
in patients with autosomal dominant retinitis pigmentosa and a
rhodopsin gene defect (PRO-23-HIS). Arch Ophthalmol 109:92101.
Berson EL, Watson G. 1980. Electroretinograms in English setters
with neuronal ceroid lipofuscinosis. Invest Ophthalmol Vis Sci 19:
87-89.
Boulton M, Moriarty P, Jarvis-Evans J, Marcyniuk B. 1994. Region
al variation and age-related changes of lysosomal enzymes in the
human retinal pigment epithelium. Br J Ophthalmol 78:125-129.
Bowes C, Li T, Danciger M, Baxter LC, Applebury ML, Farber DB.
1990. Retinal degeneration in the rd mouse is caused by a defect in
the !:I subunit of rod cGMP-phosphodiesterase. Nature 347:677680.
Bowes C, Li T, Frankel WN, Danciger M, Coffin JM, Applebury ML,
Farber DB. 1993. Localization of a retroviral element within the rd
gene coding for the beta subunit of cGl\tP phosphodiesterase. Proc
Nat Acad Sci USA 90:295.5-2959.
Budinger JM. 1961. Diphenylthiocarbazone blindness in dogs. Arch
Pathol 71:304.
Burke J, Twining S. 1988. Regional comparisons of cathepsin D ac
tivity in bovine retinal pigment epithelium. Invest Ophthalmol Vis
Sci 29:1789-1793.
Burkhardt JK, Wiebe! FA, Hester S, Argon Y. 1993. The giant or
ganelles in beige and Chediak-Higashi fibroblasts are derived from
late endosomes and mature lysosomes. J Exp Med 178:1845-1856.
Burns MS, Bellhorn RW, Impellizzeri CW, Aguirre GD, Laties AM.
1988. Development of hereditary tapetal degeneration in the bea
gle dog. Curr Eye Res 7:103-114.
Bussow H. 1980. The tapetal cell: a unique melanocyte in the tape
tum lucidum cellulosum of the cat (Felis domestica L): an electron
microscopic, cytochemical and chemical study. Anat Embryo]
158:289-302.
Butturini U, Grignolo A, Baronchelli A. 1953. "Diabete" da ditizone
aspetti metabolici oculari ed istologici. G Clin Med 34:1253-1347.
Cabral L, Cnger W, Boulton M, Lightfoot R, YkKechnie N, Grierson
I,Marshall J. 1990. Regional distribution of lysosomal enzymes in
the canine retinal pigment epithelium. Invest Ophthalmol Vis Sci
31 :670-676.
Chader GJ. 1991. Animal mutants of hereditary retinal degeneration:
General considerations and studies on defects in cyclic nucleotide
metabolism. Prog Vet Comp Ophthalmol 1:109-126.
Chader GJ, Fletcher RT, Sanyal S, Aguirre G. 1985. A review of the
role of cyclic GMP in neurological mutants with photoreceptor dys
plasia. Curr Eye Res 4:811-819.
Chang GQ, Hao Y, Wong F. 1993. Apoptosis: final common pathway
of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neu
ron 11 :595-605.
Clements PJM, Gregory CY, Petersoe-Jones SM, Sargan DR, Bhat
tacharya SS. 199j_ Confirmation of the rod cGMP phosphodi
esterase i3 subunit (PDE!:\) nonsense mutation in affected rcd-1 Irish

setters in the UK and development of a diagnostic test. Curr Eye Res
12:861-866.
Cloyd GG, Wyman M,Shadduck JA, Winrow MJ,Johnson GR. 1978.
Ocular toxicity srudies with zinc pyridinethione. Toxicol Appl Phar
macol 45:771-782.
Collier LL, Prieur DJ, King EJ. 1984. Ocular melanin pigmentation
anomalies in cats, cattle, mink, and mice with Chediak-Higashi syn
drome: histologic observations. Curr Eye Res 3:1241-1251.
Collier LL, King EJ, Prieur DJ. 1985a. Tapetal degeneration in cats
with Chediak-Higashi syndrome. Curr Eye Res 4:767-773.
Collier LL, King EJ, Prieur DJ. 19856. Aberrant melanosome devel
opment in the retinal pigmented epithelium of cats with Chediak
Higashi syndrome. Exp Eye Res 41:305-311.
Collier LL, King EJ, Prieur DJ. 1986. Age-related changes of the reti
nal pigment epithelium of cats with Chediak-Higashi syndrome. In
vest Ophthalmol Vis Sci 27:702-707.
Cummings JF, DeLahunta A, George C, Fuhrer L, Valentine BA,
Cooper BJ, Summers BA, Huxtable CR, Mohammed HO. 1990.
Equine motor neuron disease. Cornell Vet 80:357-379.
Cummings JF, DeLahunta A, Mohammed HO, Divers T.J, Summers
BA, Valentine BA, Jackson CA. 1995. Endothelial lipopigment as
an indicator of ct-tocopherol deficiency in two equine neurodegen
erative diseases. Acta Neuropathol 90:262-272.
Cummings JI<� DeLahunta A, Mohammed HO, Divers TJ. In press.
The histopathology of equine motor neuron disease (ENMD).
Equine Vet J.
Curtis R, Barnett KC, Leon A. 1987. An early-onset retinal dystrophy
with dominant inheritance in the Abyssinian cat. Invest Ophthal
mol Vis Sci 28:Bl-139.
Dawson WW, Engel HM, Hope GM, Kessler MJ, Ulshaffer RJ. 1989.
Adult-onset macular degeneration in the Cayo Santiago macaques.
PR Health Sci J 8:111-115.
DeGasperi R, Daher SA, Daniel PF, Winchester BG, Jeanloz RW, War
ren CD. 1991. The substrate specificity of bovine and feline lyso
somal alpha-D-mannosidases in relation to alpha-mannosidosis. J
Biol Chem 266:16556-16563.
Divers TJ, Mohammed HO, Cummings JF, Valentine BA, deLahunta
A, Jackson CA, Summers BA. 1994. Equine motor neuron disease:
findings in twenty-eight horses and proposal of a pathophysiologi
cal mechanism for the disease. Equine Vet J 26:409-415.
Dorey C, Wu G, Ebenstein D, Garsd A, Weiter J. 1989. Cell loss in the
aging retina: relationship to lipofuscin accumulation and macular
degeneration. Invest Ophthalmol Vis Sci 30:1691-1699.
Dryja TP, Li T. 1995. Molecular genetics of retinitis pigmentosa. Hum
Mol Genet 4:1739-1743.
Dryja TP, Berson EL, Rao VR, Oprian DD. 1993. Heterozygous mis
sense mutation in the rhodopsin gene as a cause of congenital sta
tionary night blindness. Nat Genet 4:280-283.
Dryja TP, Finn JT, Peng Y W, McGee TL, Berson EL, Yau KW. 1995.
Mutations in the gene encoding the a subunit of the rod cGMP
gated channel in autosomal recessive retinitis pigmentosa. Proc Natl
Acad Sci USA 92:10177-10181.
Edwards RB, Szamier RB. 1977. Defective phagocytes of isolated rod
outer segment.� by RCS rat retinal pigment epithelium in culture.
Science 197:1001-1003.
El Baba FE, Green WR, Fleischmann J, Finkelstein D. 1986. Clinico
pathologic correlation of lipidization and detachment of the rerinal
pigment epithelium. Am J Ophthalmol 101:.576-583.
EI-Mofry A, Gouras P, Eisner G, Balazs EA. 1978. Macular degener
ation in rhesus monkey (Macaca mulatta). Exp Eye Res 27:499.
EI-Mofty AAM, Eisner G, Balazs EA, Denlinger JL, Gouras P. 1980.
Retinal degeneration in rhesus monkeys, Macaca mulatta: survey of
three seminarural free-breeding colonies. Exp Eye Res 31:146-166.

.. y

DISEASES OF THE RPE-PHOTORECEPTOR COMPLEX IN ANIMALS
Engel HM, Dawson \l(lW, Ulshafer RJ, Hines MW, Kessler MJ. 1988.
Degenerative changes in maculas of rhesus monkeys. Ophthalmo
logica 196:143-150.
Falls HF, Wolter JR, Alpern M. 1965. Typical total monochromacy: a
histological and psychophysical study. Arch Ophthal 74:610-616.
Farber DB,Lolley RN. 1974. Cyclic guanosine monophosphate: Ele
vation in degenerating photoreceptor cells of the C3H mouse reti
na. Science 186:449-451.
Farber DB, Danciger JS, Aguirre G. 1990. Early mRNA defect in Irish
setter dog retina. Invest Ophthalmol Vis Sci (Supp). 31:310.
Farber D,Danciger JS, Aguirre G. ] 992. The f3-subunit of cyclic GMP
phosphodiesterase is deficient in canine rod-cone dysplasia 1. Neu
ron 9:349-356.
Feeney-Burns L, Ellersieck MR. 1985. Age-related changes in the ul
trastructure of Bruch's membrane. Am J Ophthalmol l 00:686-697.
Feeney-Bums L, et al. 1981. Maculopathy in cynomolgus monkeys: a
correlated fluorescein angiographic and ultrastructural study. Arch
Ophthalmol 99:664-672.
Feeney-Burns L, Hilderbrand ES, Eldridge S. 1984. Aging human
RPE: morphometric analysis of macular, equatorial and peripheral
cells. Invest Ophthalmol Vis Sci 25(1):195-200.
Fine BS. 1981. Lipoidal degeneration of the retinal pigment epitheli
um. Am J Ophthalmol 91:469-473.
Fine BS, Kwapien RP. 1978. Pigment epithelial windows and drusen:
an animal model. Invest Ophthalmol Vis Sci 17:1059.
Fishman GA, Stone EM, Gilbert LD, Sheffield VC. 1992. Ocular find
ings associated with a rhodopsin gene codon 106 mutation, glycine
to-arginine change in autosomal dominant retinitis pigmentosa.
Arch Opthhalm 110:646-653.
Fratantoni J, Hall C, Neufeld E. 1968. Hurler and Hunter syndromes:
mutual correction of the defect in cultured fibroblasts. Science 612:
500.
Gao H,Hollyfield JG. 1992. Aging of the human retina. Invest Oph
thalmol Vis Sci 33(1):1-17.
Gasper PW,T hrall MA,Wenger DA, Macy OW, Ham L, Dornsife RE,
McBiles K, Quackenbush SL, Kesel ML, Gillette EL, Hoover EL
1984. Correction of feline arylsulfatase B deficiency (mucopolysac
charidosis VI) by bone marrow transplantation. Nature 312:467469.
Gorin MB, To AC, Narfstri.im K. 1995. Sequence analysis and exclu
sion of phosducin as the gene for the recessive retinal degeneration
of the Abyssinian car. Bioch Biophys Acta 1260:323-327.
Gorin MB, Snyder S, Narfstrom K, Curtis R. 1993. The cat RDS tran
script: candidate gene analysis and phylogenetic sequence analysis.
Mamm Genome 4:544-548.
Graydon RJ, Jolly RD. 1984. Ceroid-lipofuscinosis (Banen's disease):
sequential electrophysiologic and pathologic changes in the retina
of the ovine model. Invest Ophrhalmol Vis Sci 25:294-301.
Gropp KE, Sze! A, Huang JC, Acland GM, Farber DB, Aguirre GD.
Selective absence of cone outer segment 1:13-transducin immuno
reactivity in hereditary cone degeneration (cd). Exp Eye Res
63:285-296.
Hageman GS,Johnson LV. 1991. Structure, composition and function
of the retinal interphotoreceptor matrix. In: Osborne N,Chader GJ,
eds, Progress in Retinal Research, vol. 10 Oxford: Pergamon Press.
Harrison R, Hoefnagel D, Hayward JN. 1960. Congenital total color
blindness: a clinicopathological report. Arch Ophthalmol 64:685692.
Haskins M, Baker H, Birkenmeier E, Hoogerbrugge P, Poorthuis B,
Sakiyama T, Shull R, Taylor R, Thrall M, Walkley S. 1991. Trans
plantation in animal model systems. In: Desnick R, ed, Therapy of
Genetic Disease. New York: Churchill Livingston.
Haskins M, Chieffo C,WangP,Just C,Evans 5, Aguirre G. 1992. Bone

303

marrow transplantation in canine mucopolysaccharidosis VII (beta·
glucuronidase deficiency). Am J Hum Genet 49:435.
Hayasaka S. 1974. Distribution of lysosomal enzymes in the bovine
eye. Jpn J Ophthalmol 18:233-239.
Hayes KC, Rousseau JE,Hegsted OM. 1970. Plasma tocopherol con
centrations and vitamin E deficiency in dogs. J Am Vet Med Assoc
157(1):64-71.
Heckenlively JR, Rodriguez JA, Daiger SP. 1991. Autosomal domi
nant sectoral retinitis pigmentosa: two families with transversion
mutation in codon 23 of rhodopsin. Arch Ophthalmol 109:84-91.
Herron WL, Riegel BW,Myers OE, Rubin ML 1969. Retinal dystro
phy in the rat-a pigment epithelial disease. Invest Ophthal 8:595604.
Huang J, Mieziewska K, Philp N, van Veen T, Aguirre G. 1993. Di
ethylene glycol distearate (DGD): a versatile embedding medium for
retinal cytochemistry. J Neurosci Meth 47:227-234.
Huang J, Chesselet M-F, Aguirre G. 1994. Decreased opsin mRNA
and immunoreactivity in progressive rod-cone degeneration (prcd):
Cytochemical studies of early disease and degeneration. Exp Eye
Res 58:17-30.
Huang SH, Pittler SJ, Huang X, Oliveira L, Berson EL, Dryja TP.
1995. Autosomal recessive retinitis pigmentosa caused by muta
tions in the a subunit of rod cGMP phosphodiesterase. Nature Ge
netics 11:468-471.
Humphries P, Kenna P, Farrar GJ. 1992. On the molecular genetics of
retinitis pigmentosa. Science 256:804-808.
Ishibashi T, Sorgente N, Patterson R, Ryan SJ. 1986. Pathogenesis of
drusen in the primate. Invest Ophthalmol Vis Sci 27:184-193.
Jacobson SG, Kemp CM, Narfstrom K, Nilsson SE. 1989. Rhodopsin
levels and rod-mediated function in Abyssinian cats with hereditary
retinal degeneration. Exp Eye Res 49:843-852.
Jolly RD, Palmer ON. 1995. The neuronal ceroid-lipofuscinoses (Bat
ten disease): comparative aspects. Neuropathol Appl Neurobiol
21:50-60.
Jolly RD, Shimada A, Dalefield RR, Slack PM. 1987. Mannosidosis:
ocular lesions in the bovine model. Curr Eye Res 6:1073-1079.
Jolly RD, Gibson AJ, Healy PJ, Slack PM, Birrles MJ. 1992. Bovine
ceroid-lipofuscinosis: pathology of blindness. New Zealand Vet J
40:107-11 l.
Jolly RD, Palmer ON, Studdert VP, Sutton RH, Kelly WR, Koppang
N, Dahme G, Hartley W J, Patterson JS, Riis RC. 1994. Canine
ceroid-lipofuscinoses: a review and classification. J Sm Anim Pract
35:299-306.
Kaiser JA. 1963. Tapetal depigmenration in dogs produced by ethyl
enediamines. Fed Proc 22:369.
Kajiwara K, Berson EL, Dryja TP. 1994. Digenic retinitis pigmentosa
due to mutations at the unlinked peripherin/RDS and ROMl loci
Science 264:1604-1608.
Kajiwara K, Hahn LB, Mukai S, Travis GH, Berson EL, Dryja TP.
1991. Mutations in the human retinal degeneration slow gene in au
tosomal dominant retinitis pigmentosa. Nature 354:480- 484.
Koppang N. 1992. English setter model of neuronal ceroid-lipofusci
nosis in man. Am J Med Genet 42:599-604.
Krivit W,er al. 1984. Bone-marrow transplantation in the Maroteaux
Lamy syndrome (mucopolysaccharidosis type VI). New Eng] �1ed
311:1606-1611.
Kyle JW, Birkenmeier EH, G"-','nn B, Vogler C,Hoppe PC, Hoffman
JW,Sly WS. 1990. Correction of murine mucopolysaccharidosis VII
by a human B-glucuronidase transgene. Proc Nat Acad Sci USA.
87:3914-3918.
Lai Y-L. 1980. Outward movement of photoreceptor cells in normal
rat retina. Invest Ophthalmol Vis Sci 19:849-856.
Lai Y -L,Jacoby RO, Jonas AM. 1978. Age-related and lighr-associat-

304

INHERITED AND METABOLIC DISORDERS

ed retinal changes in Fischer rats. Invest Ophthalmol Vis Sci
17:634-638.
Lai Y-L, Masuda K, Mangum RL, Macrae DW, Fletcher G, Yung-Pin
L. 1982. Subretinal displacement of photoreceptor nuclei in human
retina. Exp Eye Res 34:219-228.
Landers RA, Tawara A, Varner HH, Hollyfield JG. 1991. Proreogly
cans in the mouse interphororeceptor matrix. IV. Retinal synthesis
of chondroitin sulfate proteoglycan. Exp Eye Res 52:65-74.
Larsen H. 1921. Demonstration mikroskopischer Praparate von
einem monochromatischen Auge. Z Augenheilkunde 46:228-229.
LaVail MM. 1980. Degenerate retinal disorders: interaction of envi
ronmental light and pigmentation with inherited retinal degenera
tions. Vision Res 20:1172-1177.
LaVail MM, Battelle B. 1975. lnfluence of eye pigmentation and light
deprivation on inherited retinal dystrophy in the rat. Exp Eye Res
21:167-192.
La Vail MM, Pinto LH, Yasumura D. 1981. The interphotoreceptor
matrix in rats with inherited retinal dystrophy. Invest Ophthalmol
Vis Sci 21 :658-668.
Lazarus HS, Sly WS, Kyle JW, Hageman GS. 1993. Photoreceptor de
generation and altered distribution of interphororeceptor matrix
proteoglycans in the mucopolysaccharidosis V II mouse. Exp Eye
Res 56:531-541.
Leon A, Curtis R. 1990. Autosomal dominant rod-cone dystrophy in
the rdy cat. 1. Light and electron microscopic findings. Exp Eye Res
51:361-381.
Leon A, Hussain AA, Curtis R. 1988. Rod-cone dysplasia in the rdy
cat: electrophysiology and biochemistry. Invest Ophthalm Vis Sci
29(suppl):143.
Li T, Davidson B. 1995. Phenotype correction in retinal pigment ep
ithelium in murine mucopolysaccharidosis VII by adenovirus
mediated gene transfer. Proc :'\i"at Acad Sci USA 92:7700-7704.
Li L, Turner JE. 1988. Inherited retinal dystrophy in the RCS rat: pre
vention of photoreceptor degeneration by pigment epithelial cell
transplantion. Exp Eye Res 47:911-917.
Lightfoot, RM. 1988. Retinal pigment epithelial dystrophy in the dog.
PhD dissertation. University of London.
Long KO, Haskins ME, Aguirre GD. 1989. Photoreceptor-RPE inter
face in [3-glucuronidase deficiency: an anatomical and immunocy
tochemical study. Invest Ophthalmol Vis Sci 30(suppl):3.
Long K, Aguirre G. 1991. The cone matrix sheath in the normal and
diseased retina. Exp Eye Res 52:699-713.
Marechal V, Naffakh N, Danos 0, Heard JM. 1993. Disappearance
of lysosomal storage in spleen and liver of mucopolysaccharidosis
VII mice after transplantation of genetically modified bone marrow
cells. Blood 82:1358-1365.
Massa 1� Davis GJ, Schiavo D, Sinha DP, Szot RJ, Black HE, Schwartz
E. 1984. Tapetal changes in beagle dogs. II. Ocular changes after in
travenous administration of a macrolid antibiotic rosaramicin. Tox
icol Appl Pharmacol 72:195-200.
McLaughlin ME, Sandberg MA, Berson EL, Dryja TP. 1993. Reces
sive mutations in the gene encoding the [3-subunit of rod phospho
diesterase in patients with retinitis pigmentosa. Nat Genet 4:130134.
McLaughlin ME, Ehrhart TL, Berson EL, Dryja TP. 1995. Mutation
spectrum of the gene encoding the p subunit of rod phosphodi
esterase among patients with autosomal recessive retinitis pigmen
tosa. Proc Nat Acad Sci USA 92:3249-3253.
.'v1ieziewska K. 1993. The interphotoreceptor matrix: a study of struc
ture and composition in normal and degenerating retinas. PhD dis
sertation. University of Goteborg, Faculty of Natural Sciences.
Mieziewska K, van Veen T, Murray J, Aguirre G. 1991. Rod and cone
specific domains in the interphotorecepror matrix. J Comp Neurol
308:371-380.

Miewziewska K, van Veen T, Aguirre G. 1993a. Development and fate
of interphotoreceptor matrix components during dysplastic pho
toreceptor differentiation: a lectin cytochemical study of rod-cone
dysplasia 1. Exp Eye Res 56:429-441.
.Mieziewska K, van Veen T, Aguirre G. 19936. Structural changes of
rhe interphotoreceptor matrix in an inherited retinal degeneration:
A lectin cytochemical study of progressive rod-cone degeneration
(prcd). Inv Ophthalm Vis Sci 34:3056-3066.
Miller AD, Buttimore C. 1986. Redesign of retrovirus packaging cell
lines to avoid recombination leading to helper virus production.
Mo! Cell Biol 6:2895-2902.
Moullier P, Bohl D, Heard J-M, Danos 0. 1993. Correction of lyso
somal storage in the liver and spleen of ll,IPS VII mice by implanta
tion of genetically modified skin fibroblasts. Nat Genet 4:154-159.
Mullen RJ, LaVail .'v1M. 1976. Inherited retinal dystrophy: primary
defect in pigment epithelium determined with experimental rat
chimeras. Science 192:799-801.
Nakaizumi Y. 1964. The ultrastructure of Bruch's membrane. II. Eyes
with a tapetum. Arch Ophthalmol 77:388-394.
Narfstrom K. 1983. Hereditary progressive retinal atrophy in the
Abyssinian cat. J Hered 74:273-276.
Narfsrrom K, Nilsson SE. 1986. Progressive retinal atrophy in the
Abyssinian cat. Invest Ophthalmol Vis Sci 27:1569-1576.
Narfstri.im K, Nilsson SE. 1989. Morphological findings during reti
nal development and maturation in hereditary rod-cone degenera
tion in Abyssinian cats. Exp Eye Res 49:611-628.
Narfstri.im KL Nilsson SE, Andersson BE. 1985. Progressive retinal
atrophy in the Abyssinian cat: studies of the DC-recorded elec
troretinogram and the standing potential of the eye. Br J Ophthal
mol 69:618-623.
Narfstri.im K, Wilen M, Andersson BE. 1988. Hereditary retinal de
generation in the Abyssinian cat: developmental studies using clin
ical electrorerinography. Doc Ophrhalmol 69(2): 111-118.
Narfstrom K, Nilsson SE, Wiggert B, Lee L, Chader GJ, van Veen T.
1989. Reduced level of inrerphotoreceptor retinoid binding protein
(IRBP) a possible cause for retinal degeneration in the Abyssinian
cat. Cell Tissue Res 257:631-639.
Narfstrom K, Wrigstad A, Nilsson SEG. 1989. The Briard dog: a new
animal model of congenital stationary night blindness. Br J Oph
thalmol 73:750-756.
Narfstrom K, Wrigstad A, Ekesten B, Nilsson SEG. 1994. Hereditary
retinal dystrophy in the Briard dog: clinical and hereditary charac
teristics. Vet Comp Ophthalmol 4(2):85-92.
Keville H, Armstrong D, Wilson B, Koppang N, Wehling C. 1980.
Studies on the retina and the pigment epithelium in hereditary ca
nine ceroid lipofuscinosis III. Morphologic abnormalities in retinal
neurons and retinal pigmented epithelial cells. Invest Ophthalmol
Vis Sci 19:75-86.
:'>'icolas MG, Fujiki K, Murayama K, Suzuki MT, Mineki R,
Hayakawa M, Yoshikawa Y, Cho F, Kanai A. 1996. Studies on the
mechanism of early onset macular degeneration in cynomolgus
(Macaca fascicularis) monkeys. L Abnormal concentrations of two
proteins in the retina. Exp Eye Res 62:211-219.
�ilsson SEG, Armstrong D, Koppang N, Persson P, �1ilde K. 1983.
Studies on the retina and the pigment epithelium in hereditary ca
nine ceroid lipofuscinosis. IV: Changes in the electroretinogram and
the standing potential of the eye. Invest Ophchalmol Vis Sci
24:77-84
Nilsson SEG, Wrigstad A, Narfstrom K. 1992. Changes in the DC
electroretinogram in briard dogs with hereditary congenital night
blindness and partial day blindness. Exp Eye Res 54:291-296.
Nishimura Y, Rosenfeld MG, Kreibich G, Gubler U, Sabatini DD,
Adesnik M, Andy R. 1986. Nucleotide sequence of rat preputial
gland [3-glucuronidase cDNA and in vitro insertion of its encoded

DISEASES OF THE RPE-PHOTORECEPTOR COMPLEX lN ANIMALS
polypeptide into microsomal membranes. Proc Nat Acad Sci USA
83:7292-72.96.
Parry HB. 1954. Degenerations of the dog retina VI. Central progres
sive atrophy with pigment epithelial dystrophy. Br J Ophthal
38:653-668.
Parshall C, Wyman M, Nitroy S, Adand G, Aguirre G. 1991. Pho
toreceptor dysplasia: an inherited progressive retinal atrophy of
miniature schnauzer dogs. Prog Vet Comp Ophtholmol l:187.
Perou CM, Kaplan J. 1993. Complementation analysis of Chediak
Higashi syndrome: the same gene may be responsible for the defect
in all patients and
Somar Cell Mo! Genet 19:459-468.
Pirie A. 1966. Chemistry and structure of the tapetum lucidum. In:
Graham-Jones 0, ed, Aspects of Comparative Ophthalmology.
London: Pergamon Press, 57-68.
Pittler SJ, Baehr W. 1991. Identification of a nonsense mutation in the
rod photoreceptor cGMP phosphodiesterase [,-subunit gene of the
rd mouse. Proc Nat Acad Sci USA 88:8322-8326.
Porrello K, Yasumura D, LaVail M.\1. 1986. The interphotoreceptor
matrix in RCS rats: histochemical analysis and correlation with the
rate of retinal degeneration. Exp Eye Res 43:413-429.
Portera-Cailliau C, Sung C-H, Nathans J, Adler R. 1994. Apoptotic
photoreceptor cell death in mouse models of retinitis pigmentosa.
Proc :t\at Acad Sci USA 91:974-978.
Prince JH, Diesem CD, Eglitis I, Ruskell GL. 1960. Anatomy and His
tology of the Eye and Orbit in Domestic Animals. Springfield,
Charles C. T homas, page 219.
Ray J, Wolfe J, Haskins M, Aguirre G. 1992. Specificity of 13-glu
curonidase cDNA to correct inherited defects of the lysosomal sys
tem in the RPE. Invest Ophthalmol Vis Sci 33(suppl):909.
Ray J, Wu Y, Haskins M, Salvetti A, Heard JM, Aguirre G. 1995. En
hanced degradation of accumulating GAGs in MPS VI-affected reti
nal pigment epithelium by arylsulfatase B cDNA transfer. Inv Oph
thalmol Vis Sci 36(suppl):S918.
Ray J, DeSanto CM, Sun W, Haskins M, Aguirre G. 1996. Studies on
the molecular basis of [3-glucuronidase deficiency in mucopolysac
charidosis VII (MPS VII) in the retinal pigment epithelium. Invest
Ophthalmol Vis Sci (suppl) 37:5379.
Ray J, Wu Y, Aguirre GD. 1997. Characterization of [3-glucuronidase
in the retinal pigment epithelium. Curr. Eye Res. 16:131-143.
Ray K, Baldwin V, Acland G, Blanton S, Aguirre G. 1994. Co-segre
gation of codon 807 mutation of the rod cGMP phosphodiesterase
[3 gene (PDEB) in red!. Invest Ophthalmol Vis Sci 35:4291-4299.
Ray K, Baldwin V, Acland G, Aguirre G. 1995. Molecular diagnostic
tests for ascertainment of genotype at the rod cone dysplasia 1
(rcdl) locus in Irish setters. Curr Eye Res 14:243-247.
Ray K, Acland GM, Aguirre GD. 1996. Nonallelism of erd and prcd
and exclusion of the canine RDS/peripherin gene as a candidate for
both retinal degeneration loci. Inv Ophthalm Vis Sci 37:783-794.
Ray K, Baldwin V J, Zeiss C, Acland GM, Aguirre GD. In press. Ca
nine rod transducin a-1: cloning of the cDNA and evaluation of the
gene as a candidate for progressive retinal atrophy. Curr Eye Res
16:71-77.
Riis RC, Sheffy BE, Loew E, Kern TJ, Smith JS. 1981. Vitamin E de
ficiency retinopathy in dogs. Am J Vet Res 42:74-86.
Riis RC, Cummings JF, Loew ER, de Lahunta A. 1992. Tibetan terri
er model of canine ceroid lipofuscinosis. Am J Med Gen 42:615621.
Riis RC, Rebhun WC, Jackson CA, Loew E, Karz ML, Cummings Jf;
Mohammed HO, Divers T J, deLahunta A, Valentine BA. 1995,
Fundic lesions in horses affected with equine motor neuron disease.
Proc Am Coll Vet Ophthalm 43.
Roque RS, Imperial CJ, Caldwell R. 1996. Microglial cells invade the
outer retina as photoreceptors degenerate in Royal College of Sur
geons rats. Invest Ophthalmol Vis Sci 37:196-203.

305

Rosenzweig M, Giger U, Metzler], Valle DL, Aguirre G. I 990. Or
nithine aminotransferase deficiency in a domestic short hair cat. J
Vet Int Med 4:116.
Rubin LF, Lipton DE. 1973. Retinal degeneration in kittens. J Am Vet
Med Assoc 162:467-469.
Rushton A, Dawson G. 1977. The effect of glycosaminoglycans on the
in vitro activity of human skin fibroblast glycosphingolipid B-galac
tosidases and neuraminidases. Clin Chim Acta 80:133-139.
Sands MS, Barker JE, Vogler C, Levy B, Gwynn B, Galvin N, Sly WS,
Birkenmeier E. 1993. Treatment of murine mucopolysaccharidosis
type VII by syngeneic bone marrow transplantation in neonates.
Lab Invest 68:676-686.
Santos-Anderson RM, Tso MO.\,,1, Vainisi SJ. 1983. Heredofamiliar
retinal dystrophy in Guinea baboons. II. Electron microscopic ob
servations. Arch Ophthalmol 101:1762-1770.
Schiavo DM, Sinha DP, Black HE, Arthaud L, Massa T, Murphy BF,
Szot RJ, Schwartz E. 1984. Tapetal changes in beagles dogs. I. Oc
ular changes after oral administration of a beta-adrenergenic block
ing agent, SCH 19927. Toxicol Appl Pharmacol 72:187-194.
Schiavo DM, Green JD, Traina VM, Spaet R, Zaidi L 1988. Tapetal
changes in beagle dogs following oral administration of CGS
14796C, a potential aromatase inhibitor. Fundam Appl Toxicol 10:
329-334.
Schmidt SY, Aguirre GD. 1985. Reductions in taurine secondary to
photoreceptor loss in Irish setters with rod-cone dysplasia. Invest
Ophthalmol Vis Sci 26:679.
Smith RIE, Surton RH, Jolly RD, Smith KR. 1996. A retinal degener
ation associated with ceroid-lipofuscinosis in adult miniature
schnauzers. Vet Comp Ophthalmol 6:187-191.
Stafford TJ. 1974. Maculopathy in an elderly sub-human primate.
Mod Prob! Ophthal 12:214-219.
Stramm LE, Haskins ME, McGovern M, Aguirre G. 1983. Tissue cul
ture of cat retinal pigment epithelium. Exp Eye Res 36:91-101.
Stramm L, Haskins iv!, Desnick RJ, Aguirre G. 1985. Disease expres
sion in cultured pigment epithelium: feline mucopolysaccharidosis
VI. Invest Ophthalmol Vis Sci 26:182.
Stramm LE, Desnick RJ, Haskins ME, Aguirre GD. 1986. Arylsulfa
tase B activity in cultured retinal pigment epithelium: regional stud
ies in feline mucopolysaccharidosis VI. Invest Ophthalmol Vis Sci
27:1050.
Stramm LE, Haskins ME, Aguirre GD. 1989. Retinal pigment epithe
lial glycosaminoglycan metabolism: intracellular versus extracellu
lar pathways. Invest Ophthalmol Vis Sci 30:2118.
Stramm L, Wolfe J, Schuchman E, Haskins M, Patterson DF; Aguirre
G. 1990. j:\-glucuronidase mediated pathway essential for retinal
pigment epithelial degradation of glycosaminoglycans. Disease ex
pression and in vitro disease correction using retroviral mediated
cDNA transfer. Exp Eye Res 50:521-532.
Suber ML, Pittler SJ, Qin N, Wright GC, Holcombe V, Lee RH, Craft
CM, Lolley RN, Baehr W, Hurwitz RL. 1993. Irish setter dogs af
fected with rod/cone dysplasia contain a nonsense mutation in the
rod cGMP phosphodiesterase j:\-subunit gene. Proc Nat Acad Sci
USA 90:3968-3972.
Summers G, Purple R, Krivit W, Pineda R, Copland G, Ramsay N,
Kersey J, Whitley C. 1989. Ocular changes in the mucopolysaccha
ridoses after bone marrow transplantation. Ophthalmol 96:977.
Tamai M, O'Brien PJ. 1979. Retinal dystrophy in the RCS rat: in vivo
and in vitro studies of phagocytic action of the pigment epithelium
on the shed rod outer segments. Exp Eye Res 28:399-411.
Travis GH, Brennan MB, Danielson PE, Kozak CA, Sutcliffe JG.
198 9. Identification of a photoreceptor-specific mRNA encoded by
the gene responsible for retinal degeneration slow (rds). Nature
338:70-73,
Tso MOM, Santos-Anderson RM, Vanisi SJ. 1983. Heredofamilial

306

INHERITED AND METABOLIC DISORDERS

retinal dystrophy in Guinea baboons. I. A histopathologic Study.
Arch Ophthalmol 101(10):1597-1603.
Vainisi S, Beck B, Apple D. 1974. Retinal degeneration in a baboon.
Am J Ophthalmol 78(2):279-284.
Valle D, Boison A, Jezyk P, Aguirre G. 1981. Gyrate atrophy of the
choroid and retina in a cat. Invest Ophthalmol Vis Sci 20:251.
Valle D, Jezyk P, Aguirre G. 1983. Gyrate atrophy of the choroid and
retina. Comp Pathol Bull 15:2.
Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P,
Hofmann SL, Peltonen L. 1995. Mutations in the palmiroyl protein
thioesterase gene causing infantile neuronal ceroid lipofuscinosis.
Nature 376:584-587.
Vine D, McGovern M, Schuchman E, Haskins M, Desnick R. 1982.
Enhancement of residual arylsulfatase B activity in feline mu
copolysaccharidosis VI by thiol-induced subunit association. J Clin
Invest 69:294.
Voge! M. 1978. Postnatal development of the cat's retina. Adv Anat
Embryo! Cell Biol 54(4):7-66.
Vogel AW, Kaiser JA. 1963. Ethamhutol induces transient change and
reconstruction (in vivo) of the tapetum lucidum color in the dog.
Exp Mo! Pathol 2(suppl):136-149.
Walkley SU, Thrall MA, Dobrenis K, Huang M, March PA, Siegel DA,
Wurzelmann S. 1994. Bone marrow transplantation corrects the en
zyme defect in neurons of the central nervous system in a lysosomal
storage disease. Proc Nat Acad Sci USA 91 :2970-2974.
Wang W, Acland GM, Aguirre GD, Ray K. 1995. Exclusion of
rhodopsin, and probable exclusion of rds/peripherin, as candidates
for canine progressive rod cone degeneration (prcd). Invest Oph
thalmol Vis Sci 36(suppl):5772.
Watson P, Bedford PGC. 1992. The pigments of retinal pigment ep
ithelial dystrophy in dogs. Vet Pathol 29:5.
Watson P, Simson, KW, Bedford, PGC. 1993. Hypercholesterolaemia
in briards in the United Kingdom. Res Vet Sci 54:80-85.
Weleber RG, Carr RE, Murphey WH, Sheffield VC, Stone EM. 1993.
Phenorypic variation including retinitis pigmenrosa, pattern dys
trophy, and fundus flavimaculatus in a single family with a deletion
of codon 153 or 154 of the peripherin/RDS gene. Arch Ophthalmol
111:1531-1542.
Wen GY, Sturman JA, Wisniewski HM, Lidsky AA, Cornwell AC,
Hayes KC. 1979. Tapetum disorganization in raurine-depleted cats.
Invest Ophthalmol Vis Sci 18:1201-1206.
Wen GY, Wisniewski HM, Sturman JA. 1982. Hereditary abnormal
ity in tapetum lucidum of the Siamese cats: A histochemical and
quantitative study. Histochemistry 75:1-9.
Wen GY, Sturman JA, Shek JW. 1985. A comparative study of the
tapetum, retina and skull of the ferret, dog, and cat. Lab Anim Sci
35:200-210.
Wenger D, Gasper P, Thrall M, Dial S, LeCoteur R, Hoover E. 1986.
Bone marrow transplantation in the feline, model of arylsulfarase B
deficiency. In: Krivit W, Paul N, eds. Bone Marrow Transplantation
for Treatment of Lysosomal Storage Diseases. New York: Liss, 177.

West-Hyde Leigh DVM, Buyukmihci N. 1982. Photoreceptor degen
eration in a family of cats. J Am Vet Med Assoc 181:243-248.
Wiggert B, Kutry G, Long K, Inouye L, Gery I, Chader G, Aguirre G.
1991. lnterphotoreceptor retinoid-binding protein (IRBP) in pro
gressive rod-cone degeneration (prcd). Exp Eye Res 53:389-398.
Wiggett B, van Veen T, Kutty G, Lee L, Nickerson J, Si }S, Nilsson
SEG, Chader GJ, Narfscrom K. 1994. An early decrease in inter
photoreceptor retinoid-binding protein gene expression by Abyssin
ian cats homozygous f or hereditary rod-cone degeneration. Cell Tis
sue Res 278:291-298.
Wolf e J, Schuchman E, Stramm L, Concaugh E, Haskins M, Aguirre
G, Patterson D, Desnick R, Gilboa E. 1990. Restoration of normal
lysosomal function in mucopolysaccharidosis type VII cells by
retroviral vector-mediated gene transfer. Proc Nat Acad Sci USA 87:
2877-2881.
Wolfe JH, Sands MS, Barker JE, Gwynn B, Rowe LB, Vogler CA,
Birkenmeier EH. 1992. Reversal of pathology in murine mucopoly
saccharidosis type VII by somatic cell gene transfer. Nature 360:
749-753.
Woodford BJ, Liu Y, Fletcher RT, Chader GJ, Farber DB, Santos-An
derson R, Tso MOM. 1982. Cyclic nucleotide metabolism in in
herited retinopathy in collies: A biochemical and histochemical
study. Exp Eye Res 34:703-714.
Wrigsrad A. 1994. Hereditary dystrophy of the retina and the retinal
pigment epithelium in a strain of briard dogs: a clinical, morpho
logic and electroretinographic study. Linkoping University Medical
Dissertation #423.
Wrigstad A, Nilsson SEG, Narfstrom K. 1992. Ultrastructural
changes of the retina and the retinal pigment epithelium in briard
dogs with hereditary congenital night blindness and partial day
blindness. Exp Eye Res 55:805-818.
Wrigstad A, Narfstrom K, Nilsson SEG. 1994. Slowly progressive
changes of the retina and retinal pigments epithelium in briard dogs
with hereditary retinal dystrophy: a morphologic study. Doc Oph
thalmol 87:337-354.
Wrigstad A, Nilsson SEG, Dubielzig R, Narfstrom K. 1995. Neuronal
ceroid lipofuscinosis in the Polish Owczarek Nizinny (PON) dog.
Doc Ophthalmol 91:33-47.
Wyszynski RE, Bruner WE, Cano DB, Morgan KM, Davis CB, Stern
berg P. 1989. A donor-age-dependent change in the activity of
alpha-mannosidase in human cultured RPE cells. Invest Ophthal
mol Vis Sci 30:2341-2347.
Zhao H, Boissy Y L, Abdel-Malek Z, King RA, Nordlund JJ, Boissy
RE. 1994. On the analysis of the pathophysiology of Chediak
Higashi syndrome: def ects expressed by cultured melanocytes. Lab
Invest 71:25-34.
Zimmerman W, Godchaux W, Belkin M. 1983. The relative propor
tions of lysosomal enzyme activities of bovine retinal pigment ep
ithelium. Exp Eye Res 36:151-158.

